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Annie J. Rohan 
 
Background:  Ongoing stress has costs in brain and body adaptations.  Recurrent and 
prolonged stress taxes the adaptive capacity of the premature infant and has been 
postulated as a risk factor for the development of later disease (Sullivan, Hawes, 
Winchester, & Miller, 2008).  Cortisol appears to be an important mediator in the 
relationship between prolonged stress and subsequent disease and disability.  Neonatal 
Intensive Care Unit (NICU) stress may give rise to early recognizable patterns of adrenal 
axis adaptation in prematurely born infants.  These adaptations may underlie difficulties 
in learning and development for a population of children that already bears a high burden 
of disease.  Premature infants who spend their first weeks of life in the NICU have been 
shown to have altered glucocorticoid values at approximately one year of age (Grunau et 
al., 2007; Grunau, Weinberg, & Whitfield, 2004; Haley, Weinberg, & Grunau, 2006).  It 
is hypothesized that adaptations of the adrenal axis may begin to emerge even earlier - 
during NICU hospitalization - and in relation to recurrent pain-associated procedural 
exposure or the prolonged stress of assisted ventilation.  




Objective:  The primary purpose of this research was to examine the relationship 
between random cortisol values at 37 postmenstrual weeks of age and pain-associated 
stressor exposure in prematurely born infants who received extended care in the NICU.  
Because random cortisol values in premature infants have been shown to be relatively 
dissociated from clinical conditions, this research also explored the relationship between 
values of the cortisol precursor, 17-hydroxyprogesterone (17-OHP), and pain-associated 
stressor exposure in prematurely born infants.   
Methods:  A descriptive, cross-sectional design was used to examine relationships 
between two major types of pain-associated stressor exposures - number of recurrent 
skin-breaking procedures and hours of assisted ventilation - and random serum cortisol 
and 17-OHP values at 37 postmenstrual weeks of age.  Subjects were 59 infants born at 
under 35 completed weeks of gestation, who were at least two weeks of age, and who had 
been cared for in in the NICU since birth.  Infants with intrauterine growth restriction, 
major anomalies, or exposure to postnatal steroids or surgery were excluded. 
Results:  During this study, the 59 prematurely born infants were collectively exposed to 
over 3350 pain-associated procedures and over 17,000 hours of assisted ventilation.  The 
greatest number of individual pain-associated exposures was 238, and no infant was 
exposed to less than 20 procedures (mean = 57).  Over half of these exposures were in the 
first week after birth.  There was a significant negative correlation (Spearman rank, one-
tailed) between recurrent pain-associated stressor exposure in premature infants and their 
values of 17-OHP at 37 postmenstrual weeks of age (r= -0.232, p=0.039).  A trend was 




also identified for differences in 17-OHP values between infants who had the highest and 
lowest recurrent pain-associated stressor exposure (U=68.5, p=0.068).  No significant 
relationships were identified between cortisol values and any of the study variables.  Due 
to multicollinearity, it was not possible to examine the independent effects of recurrent 
pain-associated stressor exposure, gestational age, chronological age or hours of 
ventilation on 17-OHP values.  One-tailed correlation analyses, however, failed to 
identify any significant relationships between the collinear variables or birthweight and 
17-OHP values.  
Conclusions:  Premature infants are exposed to a high number of recurrent skin-breaking 
procedures while receiving care in the NICU, especially during their first week of age.  
There is a statistically significant relationship between the incidence of these recurrent 
pain-associated procedures and an aspect of the adrenocorticoid profile at 37 
postmenstrual weeks of age.  Recurrent pain-associated stressor exposure may be a more 
important factor in explaining the variance of 17-OHP values at 37 postmenstrual weeks 
of age than birthweight, gestational age, chronological age or hours of assisted 
ventilation. 
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CHAPTER 1: Introduction 
The rate of premature birth continues to rise in most countries (World Health 
Organization, 2012).  Recent reports indicate that the United States now has a premature 
birth rate exceeding 12 percent of all live births, and is faced with over 543,000 
prematurely born infants each year (National Center for Chronic Disease Prevention and 
Health Promotion - Division of Reproductive Health, 2010).  In addition, although the 
rate of premature birth continues to rise worldwide, preterm birth rates in the United 
States are higher than 130 other countries who report these statistics, including many 
poorer nations (World Health Organization, 2012).  Most premature infants will require 
specialized hospital care.  For many, this care will be carried out over several weeks or 
months in a Neonatal Intensive Care Unit (NICU).  
Stress is a condition of the human experience, and also a factor in the expression of 
disease.  It is not just the toll of dramatic life events, but rather the many events of daily 
life that elevate activities of physiologic systems and cause some measure of wear and 
tear on these systems (McEwen & Seeman, 1999).  An agent that produces a demand on 
the body is known as a stressor.  Stressors include agents such as light, noise, cold, tissue 
trauma and infection.  Some neuroscientists are beginning to transform the way we think 
about stress by proposing that stress refers to conditions whereby an agent’s demand for 
adaptation exceeds the natural regulatory capacity of the organism (Koolhaas et al., 
2011). 
Care in the NICU is stressful for infants.  As a consequence of caretaker efforts to 




their ability to maintain physiologic homeostasis.  These interventions include diagnostic 
testing, nursing procedures, and treatments that have therapeutic intent.  Painful stimuli 
are stressful, particularly for infants (Gunnar, Talge, & Herrera, 2009; Whitfield & 
Grunau, 2000).  Skin-breaking procedures and mechanical ventilation impart a significant 
burden of pain and stress on premature hospitalized infants (Aranda et al., 2005; 
Cignacco et al., 2009; Porter, Wolf, Gold, Lotsoff, & Miller, 1997).    
For many years, researchers have been interested in the long-term effect of stress on 
health and disease (Selye, 1976; Selye & Horava, 1953).  The term allostasis was 
introduced by Sterling and Eyer in 1988 to describe the active process by which the body 
predicts, responds and adapts to daily events and stressors to maintain homeostasis 
(Sterling & Eyer, 1988).  The term allostatic load was introduced in 1993 by McEwen 
and Stellar to describe the cumulative physiologic toll of repeated attempts at stress 
adaptation.  These researchers proposed that allostatic load was “the strain on the body 
produced by repeated ups and downs of physiologic response, as well as by the elevated 
activity of physiologic systems under challenge…” (McEwen & Stellar, 1993).  Early life 
elevations in allostatic load are postulated to increase vulnerability to physical disease 
and psychosocial disorders (Gunnar, Frenn, Wewerka, & Van Ryzin, 2009; S. M. Korte, 
Koolhaas, Wingfield, & McEwen, 2005; Lupien, McEwen, Gunnar, & Heim, 2009; 
McEwen, 2001; McEwen & Wingfield, 2003).   
The hypothalamic-pituitary-adrenal (HPA) axis is the major physiologic system 
responsible for regulating hormonal stress response.  Recurrent and prolonged activation 




outcomes.  Stress activates the HPA axis, exposing tissues to elevated concentrations of 
glucocorticoids.  Chronically high levels of these hormones damage tissues or can give 
rise to adrenal axis adaptations.  These adaptations shield the body from excessive 
glucocorticoid exposure by modifying adrenal hormone response or function.  While 
initially protective, these developmental adaptations may compromise the ability of the 
organism to adequately modulate stress later in life.  It is postulated that early alterations 
in adrenocorticoid production is a mechanism that impedes the return of normal long-
term psychological, social and physical functioning when environmental conditions 
improve (Dowd, Simanek, & Aiello, 2009; Phillips, 2001, 2007; Sullivan, Hawes, et al., 
2008; Ward et al., 2004).   
An  increasing body of evidence supports that stressful events in fetal and early life 
permanently alter the adrenocorticoid phenotype (Clark, 1998; Cutfield et al., 2004; Seckl 
& Holmes, 2007; Ward, Syddall, Wood, Chrousos, & Phillips, 2004; Xita & Tsatsoulis, 
2010).  While elevated levels of infant stressor exposure during NICU hospitalization is 
reasonably accepted for extended survival, high cumulative exposure to stressors may 
nevertheless modify HPA axis activity and predispose premature infants to additional 
disease, compromised functioning, or homeostatic dysregulation throughout their lives.  
This may be particularly manifest in the smallest and sickest patients, in whom diagnostic 
and life-sustaining therapies are associated with the highest overall exposure to pain-
associated stressors (D. P. Barker & Rutter, 1995).   
Despite a literature supporting a link between allostatic load, adrenal axis adaptation and 




chronic or repetitive stress in the neonatal period and early adrenal axis adaptation.  Little 
is known about the early adrenocorticoid phenotype that evolves following exposure by 
premature infants to prolonged and recurrent stressors in the NICU environment.  
Examination of adrenal axis adaptations in prematurely born infants is particularly 
compelling, as this is a relatively large pediatric population with a significant lifetime 
burden of cognitive, psychological and physical disease.   
Problem Statement 
Ongoing stress has costs in brain and body adaptations.  Recurrent and prolonged stress 
taxes the adaptive capacity of the premature infant and can result in biological and 
physiological changes that have been postulated as a risk factor for the development of 
later disease (Cutfield, et al., 2004; Grunau, et al., 2007; Sullivan, Hawes, et al., 2008).   
Adrenal axis adaptations may predispose a population of medically fragile infants to 
superimposed health problems.   
Chronic or repeated stress in infancy may give rise to early recognizable alterations of the 
adrenocorticoid phenotype.  There is increasing evidence that very premature infants, 
who spend their first weeks in the NICU, have altered cortisol secretion subsequent to 
hospital discharge (Grunau, et al., 2007; Grunau et al., 2010; Grunau, et al., 2004; Haley, 
et al., 2006).  There is reason to believe that adrenocorticoid adaptations emerge even 
earlier, and in relation to recurrent exposure to painful stimuli or to the stress of 
mechanical ventilation during NICU care.   
The effect of stress in the neonatal period, and the extent to which the infant’s adrenal 




understood.  Examining the relationship between major types of stressor exposures and 
glucocorticoid hormone values during NICU hospitalization adds to our understanding of 
the relationship between stress, allostasis and developmental adaptation in prematurely 
born infants. 
Research Purpose and Study Objectives 
The primary purpose of this research was to examine the relationship between pain-
associated stressor exposure and the activity of adrenocortical hormones – the mediators 
of stress responses - at 37 postmenstrual weeks of age in prematurely born infants.  The 
broad-acting hormone, cortisol, has been important in stress research, and was the 
primary adrenocortical hormone identified for examination in this study.  The literature, 
however, suggests that cortisol values in premature infants may not be predictably 
influenced by clinical events, and that cortisol precursors may better reflect stressor 
exposure in this population.  Therefore, in addition to cortisol, this research also explored 
the relationship between 17-hydroxyprogesterone (17-OHP) values at 37 postmenstrual 
weeks of age and pain-associated stressor exposure in prematurely born infants.   
The examination of 17-OHP as a potential biomarker for stress, was more appealing than 
the examination of any other cortisol precursor or HPA axis hormone because all 
newborn infants have a random 17-OHP level drawn as part of hospital state screening 
processes for congenital adrenal hyperplasia.  By choosing 17-OHP for examination, this 
research capitalized on a potential opportunity to use a broadly existing piece of clinical 




Research Question, Specific Aims and Hypotheses 
This research study was developed to answer the following question:   
What is the relationship between recurrent exposure to pain-associated procedures 
or hours of assisted ventilation and random cortisol and 17-OHP values at 37 
postmenstrual weeks of age in premature infants who have been cared for in the 
NICU?    
The specific aims associated with this question were as follows:   
1) To characterize the nature of recurrent pain-associated procedures for premature 
infants in the NICU from birth up until the 37
th
 postmenstrual week of age 
2) To examine relationships between recurrent exposure to pain-associated 
procedures, hours of assisted ventilation, and random cortisol and 17-OHP values 
at 37 postmenstrual weeks of age in a sample of premature infants who had 
received care for a minimum of two weeks in the NICU 
There were two hypotheses associated with the second research aim: 
1) Recurrent exposure to pain-associated procedures and hours of assisted 
ventilation will be negatively correlated with random cortisol values at 37 
postmenstrual weeks of age. 
2) Recurrent exposure to pain-associated procedures and hours of assisted 
ventilation will be negatively correlated with random 17-OHP values at 37 





The life cycle model of stress developed by Lupien, McEwen, Gunnar and Heim was 
incorporated as the conceptual framework for this study (Figure 1.1) (Lupien, et al., 
2009).   
Lupien, McEwen, Gunnar and Heim (2009) developed a model for explaining the 
emergence of different disorders as they are temporally related to stress exposure.  This 
“life cycle model of stress” postulates that stressor exposure has enduring effects on the 
brain through activation of the HPA axis and release of glucocorticoids, with maximum 
neurodevelopmental impact at the time of stressor exposure.  Stress during 
developmentally sensitive periods has particular capacity to alter neural development and 
produce enduring changes in stress responsivity.  
This research focuses on the examination of pain-associated stressors as a possible 
foundation for early differentiation effects in the HPA axis of premature infants.  Specific 
to this research, the model identifies that brain structures are vulnerable to change by 
significant stressor exposures as early as the first few weeks of age.  Depending on the 
exposure, there can be changes in developing brain structures, evidenced by early 
increases or decreases in glucocorticoid production.   
Lupien’s model guided development of this research’s directional hypothesis by 
identifying that traumatic stressful exposures in the prenatal and postnatal periods may 
reprogram the HPA axis toward diminished glucocorticoid production.  Pain-associated 
procedural stress can be likened to early trauma, and was therefore hypothesized to be 




model of stress provided an appropriate conceptual framework for this cross sectional 
exploration of the relationship between NICU pain-associated stressor exposure and 
glucocorticoid values. 
 
Figure 1.1.  The Life Cycle Model of Stress. 
 
The life cycle model of stress explains the impact of chronic or repeated 
stressor exposures at different life stages.  Stress in the postnatal 
period can be associated with elevated or depressed levels of 
glucocorticoid production, depending on the exposure. For stress 
related to early trauma, the sensitive period of postnatal brain 
development that is relative to this study is circled, along with the 




Assumptions underlying this study have included: 
 1) Skin breaking procedures that are characterized as painful in the clinical 




experience similar procedures, are inherently painful and considered to be painful in 
infants. 
 2) Assisted ventilation, which involves painful procedures such as suctioning 
and intubation, is stressful in infants, consistent with evidence in older populations. 
 3) Premature infants respond to painful procedures and stressful conditions 
with an adrenocortical stress response.  
 
Significance  
This study examines the relationship between cortisol and 17-OHP values at 37 
postmenstrual weeks of age and pain-associated stressor exposure from two major 
sources in premature infants during hospitalization in the NICU.  This study is the first to 
describe both cortisol and 17-OHP values in relation to recurrent pain-associated stressor 
exposure and hours of assisted ventilation at 37 postmenstrual weeks of age. 
The information gained by this research also adds to our ability to objectively describe 
the experience of stress in premature infants who receive care in the NICU.   Few studies 
have quantified recurrent pain-associated procedural exposure in premature infants 
during NICU hospitalization, although it is commonly described as high.  In the course of 
this research, using counts of skin-breaking procedures, a more accurate representation of 
pain-associated stressor exposure has emerged.  This information can be used to further 
develop methods for pain and stress measurement in premature infants, or to develop 




Finally, this study extends what is known about factors influencing the adrenocorticoid 
phenotype of premature infants at 37 postmenstrual weeks of age.  Few studies have 
described the adrenocorticoid phenotype in premature infants in relation to pain-
associated stressors.  The information gained by this research can inform future work 
examining the impact of stress on premature infants and help us to understand the 





CHAPTER 2: Review of the Literature 
This chapter presents a review of the literature relevant to this study.  This review will 
begin with a summary of research exploring the main variables pertinent to the study, and 
move to a review of the literature in which the main variables are examined in 
relationships.  The first sections of this chapter present an overview of neurologic 
development and introduce cortisol and 17-OHP as part of the stress response system in 
infants.  This overview is followed by an examination of stress and pain in infancy, with 
attention to literature describing the measurement of these variables.  The next section 
presents a brief overview of research examining the relationship between stressful early 
life exposures and neurodevelopmental outcomes.  The final section of this chapter will 
present what is known of the relationship between pain or pain-associated stress and the 
adrenocorticoid phenotype of premature infants who have been cared for in the NICU.   
Overview of Neurologic Development and the Infant HPA System  
The nervous system is divided into peripheral and central components.  The central 
components comprise the brain and spinal cord, while the peripheral components consist 
of cranial and spinal nerves, and a network of somatic, visceral and motor neuronal 
structures that connect the integrating central components to the rest of the body.   
The peripheral nervous system can be further organized into the somatic nervous system 
and the autonomic motor system.  The somatic nervous system primarily serves the frame 
of the body, conducting impulses from skeletal muscle to central components, while the 
autonomic nervous system serves the involuntary visceral muscles and glands.  It is the 




while the autonomic nervous system, and its sympathetic and parasympathetic divisions, 
that are responsible for regulating homeostasis.  In general, the sympathetic division of 
the autonomic nervous system regulates homeostasis by responding to stress, while the 
parasympathetic division regulates homeostasis through the promotion of growth, energy 
conservation, and system restoration.   
The embryology of pain and nociception.  For pain to be perceived, nociceptive 
pathways between peripheral receptors, the spinal cord, the thalamus and the cerebral 
cortex must be intact.  Peripheral sensory receptors have been identified in the human 
fetus within the first two months of gestation, and have spread to all cutaneous surfaces 
by the 20th week of gestation (Fernandez & Watterberg, 2009; Lecanuet & Schaal, 
1996).  By the eighth week of gestation, connections from the periphery to the spinal cord 
have begun to develop (Glover & Fisk, 1999).  These synaptic interconnections are 
completed between 20 and 24 weeks gestation (Anand & Hickey, 1987). 
The cerebral cortex starts to form at ten weeks of gestation and develops as a layered 
structure (Glover & Fisk, 1999).  One layer - the cortical plate - will eventually form the 
deep structures of the mature cortex.   By 28 weeks of gestation, thalamic fibers penetrate 
this cortical plate.   Synaptogenesis of the cortical plate suggests a fully integrated 
cortical pathway (Kostovic & Judas, 2010; Lagercrantz & Changeux, 2009).   The 
development of thalamocortical connectivity is a major neurodevelopmental event in late 
gestation, allowing for sensory experiences, such as pain (Vanhatalo & van 
Nieuwenhuizen, 2000).  Studies have confirmed that pain-associated stressors activate 




(Lagercrantz & Changeux, 2009), and it is generally acknowledged that thalamocortical 
pathways allowing for pain perception are intact by 28 weeks of gestation (Anand & 
Hickey, 1987; Kostovic & Judas, 2010; S. Lee, Ralston, Drey, Partridge, & Rosen, 2005).  
Cortical development, however, continues long after birth (Glover & Fisk, 1999). 
Myelination of neuronal tissue is similarly not complete at the time of full-term birth, and 
continues through the first year of life (Deoni et al., 2011).  Prior to the 1980s, it was a 
common assumption that infants were unable to perceive pain due to the immaturity of 
their nervous system and deficiency of myelinated nerve fibers  (Unruh, 1992).  
Researchers have since identified that nociceptive impulses can travel through 
unmyelinated peripheral nerve fibers, and have suggested that lack of myelination, in 
terms of capacity for pain perception, is offset by short inter-neuron distances in infants, 
as well as a relative density of cutaneous nerve endings (Anand & Carr, 1989; Lecanuet 
& Schaal, 1996).   
The stress response system.   Autonomic responses to environmental or internal 
stressors that are identified by peripheral receptors are coordinated through the central 
nervous system.  When activated, the sympathetic division of the autonomic nervous 
system can affect changes in heart rate and bronchial tone to support organism defense, 
as well as adrenergic activities that stimulate metabolism.   
There are two interrelated sympathetic systems of stress response: the sympathetic-
adrenomedullary (SAM) system, and the hypothalamic-pituitary-adrenocortical (HPA) 
system.  The SAM system effects rapid mobilization of catecholamines from the adrenal 




swift blood supply and energy to the brain and muscles to rapidly fuel defensive 
responses.  In contrast, the HPA system affects the release of glucocorticoids, including 
cortisol from the adrenal cortex, which promotes bodily adaptations through changes in 
gene expression (Greenspan & Gardner, 2004; Gunnar & Quevedo, 2007). 
A cascade of biochemical events precedes the release of the cortisol glucocorticoid from 
the adrenal cortex after HPA axis activation.   In response to stress, integrated central 
nervous system activity cause corticotrophin-releasing hormone (CRH) and arginine 
vasopressin (AVP) to be released from the paraventricular nuclei of the hypothalamus.  
These hormones are carried to the anterior pituitary gland, where they effect 
adrenocorticotropic hormone (ACTH) release (Greenspan & Gardner, 2004; Stansbury & 
Gunnar, 1994).    
ACTH interacts with receptors of the adrenal cortex and cholesterol substrate, stimulating 
biosynthesis of cortisol.  Early in this cascade, pregnenolone is produced and partly 
converted to progesterone with the enzymatic influence of 3β-hydroxysteroid 
dehydrogenase (3β-HSD).  These substances are then converted to either 17-OH 
pregnenolone or 17-OH progesterone (17-OHP) under the influence of the enzyme 17-α –
hydroxylase, and then converted to 11-deoxycortisol under the influence of 3β-HSD and 
21-hydroxylase.  Finally, enzymatic activity of 11β-hydroxylase facilitates the conversion 
of 11-deoxycortisol to cortisol.  This end product is released into the circulation where it 
is carried to target organs through the bloodstream. A negative feedback loop to the 
hypothalamus and pituitary supports the regulation of cortisol production (Greenspan & 




corticosteroid receptors and serves as a major regulator of HPA axis sensitivity to 
negative feedback (Jacobson & Sapolsky, 1991).  This hippocampal region has 
additionally received attention for its particular vulnerability to disruption following 
stress (Carrion, Weems, & Reiss, 2007; McEwen, 2007). 
Cortisol is the primary hormonal glucocorticoid product of HPA axis activation.  Once 
circulating, most of this glucocorticoid binds to cortisol binding globulin (CBG) to form 
cortisone.  It is the unbound circulating cortisol that is biologically active and can enter 
the cells of target tissues.  Upon entering these tissues, cortisol interacts with receptors, 
crosses into the cell nucleus, and regulates the transcription of genes.  This process exerts 
effects on physiology and behavior for extended periods of time (Gunnar & Quevedo, 
2007; Stansbury & Gunnar, 1994).   
Cortisol has a role in glucose homeostasis, electrolyte balance, and the facilitation of free 
water excretion, as well as having potent anti-inflammatory effects and immune-
regulatory properties.  Cortisol and its precursor hormones affect central nervous system 
activity, and influence emotion, memory and cognition (Fernandez & Watterberg, 2009; 
Stansbury & Gunnar, 1994).   
The HPA system is highly responsive to conditions that threaten homeostasis.  The 
cascade of events that occur in response to stressors, and that result in the release of 
catabolic adrenal glucocorticoids, allow the body to increase levels of energy substrates 
such as glucose, free fatty acids and amino acids.  In addition, these glucocorticoids 
suppress immunologic responses such as inflammation at a time when mobility is 




risk for the organism by leading to adaptations that present as insulin resistance, 
hypertension, hyperlipidemia, impaired growth, muscle atrophy and immunosuppression. 
To protect against chronic excessive exposure to glucocorticoids, the organism has a 
propensity for adaptation.  Cortisol resistance is one such adaptation that has been 
supported by the literature.  In this state, higher basal levels of circulating hormone are 
indicators of target tissue insensitivity.  Hypocortisolism is another such adaptation, 
whereby the pituitary does not vigorously respond to CRH, and lower basal levels of 
circulating hormone are consequently measured.  These changes are advantageous if 
adaptations are toward a “defensive phenotype,”  that is, modified for adversity (Phillips 
& Matthews, 2011).  While such adaptations to stress have been suggested to have 
evolutionary value, for humans in our modern world, there may be a mismatch between 
the adrenocorticoid phenotype that evolves of significant early life stress and the 
subsequent less demanding environment in which the child will develop and remain in 
later life (Glover, O'Connor, & O'Donnell, 2010).   
Three major pathways can mediate an adrenocorticoid stress response and release of 
cortisol: (1) visceral and sensory stimulation, such as that produced by pain or 
temperature changes, (2) direct activation of the pituitary and hypothalamus by chemical 
stimulation, and (3) transmission of psychological stimuli from the cerebral cortex via the 
limbic circuits (Stansbury & Gunnar, 1994).  For infants, in whom the study of 
psychological stimuli is precluded by early developmental stage, adrenocorticoid stress 




Development of the HPA axis.  The development of the hypothalamic-pituitary axis is a 
complex process which depends upon fetal hypothalamic and pituitary function, and is 
influenced by placental hormones and other elements. 
The fetal adrenal cortex develops as two structural zones –a large fetal zone that produces 
dehydroepiandrosterone sulfate (DHEAS), and a smaller definitive zone that produces 
mineralocorticoids.  A functional third zone produces glucocorticoids.  Enzymatic 
activity of 11β-hydroxysteroid dehydrogenase Type II (11β-HSD Type II) in the fetal 
zone of the developing adrenal cortex has a role in cortisol regulation.  This enzyme 
causes conversion of cortisol to cortisone in the developing fetus, resulting in relatively 
high fetal levels of this biologically inactive compound (Bolt, van Weissenbruch, 
Lafeber, & Delemarre-van de Waal, 2002).   
Different from adult cortisol production processes, the fetal adrenal cortex has low 
expression of 3β-hydroxysteroid dehydrogenase, preventing significant conversion of 
pregnenolone into progesterone.  The placenta is thought to be largely responsible for this 
conversion during gestation, until the expression of this enzyme increases after birth.  
The placenta, however, lacks expression of 17-α-hydroxylase, so placental progesterone 
is transported to the fetal adrenal cortex for hydroxylation into 17-OH pregnenolone and 
17-OHP to take place (Bolt, van Weissenbruch, Lafeber, et al., 2002).  During fetal 
development, the placenta also synthesizes several other hormones, including CRH and 
ACTH, which are important regulators of fetal cortisol.   
Regulation of cortisol concentrations in the fetus is affected by placental estrogens which, 




of active cortisol into biologically inactive compound.  Reduced cortisol concentration in 
the fetus impacts the negative feedback loop to the fetal hypothalamus and pituitary.  
Inhibition of this loop causes an increase in fetal CRH and ACTH secretion, which 
results in extensive growth of the adrenal cortex during the latter part of gestation (Bolt, 
van Weissenbruch, Lafeber, et al., 2002; Midgley et al., 2001).   
The adrenal gland displays structural and functional changes during the transition from 
intrauterine to extrauterine life when the feto-placental unit ceases to exist.  Structurally, 
the fetal zone of the adrenal cortex declines rapidly in size after term birth (Midgley, et 
al., 2001).  Functional development continues after birth as the newborn adapts to 
extrauterine life.  This structural and functional development varies between premature 
infants and full-term infants.  The fetal zone, for example, persists in premature infants, 
with continued function believed to be related to maturity from conception, rather than 
days from birth (Midgley et al., 1998). 
Characterization of adrenocorticoid phenotype in term and premature infants.  
Studies of homeostasis and stress response have been facilitated by biochemical assays of 
the hormones or metabolites of the HPA system.   These assays have been widely 
available for many years (Esteban & Yergey, 1990; Gaskell & Sieckmann, 1986).  
Studies of adrenocorticoid function in term and premature infants accordingly date back 
several decades.   
Beginning in the late 1980’s, Gunnar and colleagues conducted numerous studies 
examining the strength and stability of adrenocortical response in term newborns 




& Isensee, 1989; Gunnar, Connors, Isensee, & Wall, 1988; Gunnar, Fisch, Korsvik, & 
Donhowe, 1981; Gunnar, Fisch, & Malone, 1984; Gunnar, Hertsgaard, Larson, & 
Rigatuso, 1991; Gunnar, Isensee, & Fust, 1987; Gunnar, Larson, Hertsgaard, Harris, & 
Brodersen, 1992; Gunnar, Malone, Vance, & Fisch, 1985; Hertsgaard, Gunnar, Larson, 
Brodersen, & Lehman, 1992; Larson, Gunnar, & Hertsgaard, 1991; Larson, White, 
Cochran, Donzella, & Gunnar, 1998; Malone, Gunnar, & Fisch, 1985; Stang, Gunnar, 
Snellman, Condon, & Kestenbaum, 1988).  From the work of Gunnar and colleagues, it 
was learned that the adrenocortical system in newborns was responsive to stimulation, 
and that infant behavioral stability was largely independent of stability in adrenocortical 
activity.   In addition, both basal cortisol levels and cortisol response levels were found to 
decline in the first year of life in healthy infants who were born at term. 
Wittekind and colleagues conducted one of the earliest studies examining adrenal steroid 
levels longitudinally in premature infants (Wittekind, Arnold, Leslie, Luttrell, & Jones, 
1993).  Using a sample of 25 infants with a mean gestational age of 28 weeks, researchers 
examined the influence of clinical state and glucocorticoid administration on plasma 
ACTH and cortisol levels.   Random morning serum values were drawn at 1, 2, 4 and 8 
weeks of age in these infants.  Mean cortisol values significantly decreased from week 
one to week eight, without correlation between plasma cortisol and ACTH values.  
Cortisol values were highly variable and at no time were significantly different between 
sick and well infants.  Postnatal glucocorticoid exposure was significantly correlated with 
lower ACTH values at 8 weeks of age, while exposure to antenatal steroids did not alter 




Other research has also identified that cortisol levels overlap between infants who are 
experiencing significant illness and those who are not.   In 1989, Lee and colleagues 
compared the cortisol and 17-OHP levels of 9 sick premature infants (mean gestational 
age 32.7 weeks, requiring mechanical ventilation) to 13 well premature infants (mean 
gestational age 33.5 weeks, not requiring mechanical ventilation) (M. Lee, Rajagopalan, 
Berg, & Moshang, 1989).   Cortisol levels were low in both groups.  Sick premature 
infants were found to have higher mean 17-OHP values than well premature infants, 
although there were wide ranges and many overlapping values.   
Several explanations for relative cortisol insufficiency in premature infants have been 
proposed.  There may be a rate-limiting step in the synthesis of cortisol that is 
exacerbated under chronic stress (C. Korte et al., 1996).  Alternatively, an immaturity, 
deficit or deactivation of adrenal enzyme activity in stressed premature infants may result 
in labile early cortisol levels despite high levels of stress and elevated cortisol precursor 
levels (Arnold et al., 1997; Huysman, Hokken-Koelega, De Ridder, & Sauer, 2000; 
Nykanen, Heinonen, Riepe, Sippell, & Voutilainen, 2010; Wallace et al., 1987).  Low 
levels of circulating proteins in sick premature infants is another possible etiology for  
blunted cortisol activity in premature infants (Langer, Modi, & Agus, 2006).   
Other research teams have reported labile cortisol and 17-OHP values in premature 
infants that are widely ranging and independent of degree of illness (Kaye et al., 2006; 
Lacey et al., 2004; J. Lee et al., 2008a; Martins & Procianoy, 2007; Nordenstrom, 
Wedell, Hagenfeldt, Marcus, & Larsson, 2001).   Using SNAP scores and other measures 




disproportionately low given their high burden of disease (Fernandez, Montman, & 
Watterberg, 2008, 2010; Hanna et al., 1997; Heckmann et al., 2005; Merce Fernandez-
Balsells et al., 2010; Wittekind, et al., 1993).  Cortisol response to surgical stress has 
additionally been shown to be sluggish in premature infants (Fernandez, et al., 2010).  
After considering the labile cortisol values found in premature infants, and higher 
variability in precursor values, some researchers have proposed the examination of 
precursor, or precursor to cortisol ratios in research (Franck & Miaskowski, 1997; 
Watterberg, Gerdes, & Cook, 2001).    
Chronic intrauterine stress appears to have a directional effect on 17-OHP levels.  In 
2008, Ersch and colleagues examined 17-OHP values on the first day of age in 90 
premature (25-33 weeks) infants and identified endocrinologic alterations in infants who 
had been exposed to chronic - but not acute - intrauterine stress  (Ersch, Beinder, 
Stallmach, Bucher, & Torresani, 2008).  For infants born to mothers with chronic stress 
(evidenced by preeclampsia), 17-OHP values measured in first 3 hours of age were 
significantly higher than in infants born to mothers with acute stress (evidenced by 
chorioamnionitis).  In this study, antenatal steroid exposure was not found to impact 17-
OHP values.  The presence of intrauterine growth restriction (IUGR) exacerbated the 
elevation of 17-OHP values under the condition of chronic stress. 
Bolt and colleagues proposed that the maturation of the adrenal cortex is more closely 
linked  to age from conception than to age at birth (Bolt et al., 2002a).  In research testing 
the hypothesis that adrenal function is programmed from the time of conception rather 




examining the values of 17-OHP and steroid metabolites in premature and term infants in 
the first two months of age (Wallace, et al., 1987).  Serum 17-OHP levels were first 
examined in 285 infants (142 premature and 143 term) between days 6 and 10 of age.  
Researchers concluded that serum 17-OHP levels were inversely related to gestational 
age.  Next,  researchers examined 17-OHP levels at eight points in the first month of age 
in a group of eight infants born between 33 and 35 weeks of gestation, and compared 
them to levels from a group of infants born between 26 and 32 weeks of gestation.  
Researchers identified differences in the patterns of 17-OHP after birth between these 
groups.  The 17-OHP levels in less mature infants fell in the first week of age, but then 
increased progressively to nearly birth levels by day 25 of age.  In the more mature 
infants, an initial drop in 17-OHP levels was noted; however a secondary rise was not 
evident.   
Subsequent studies describing adrenocorticoid values for premature infants have 
generally examined these values during the first week or two of age, or report values in 
terms of chronological age (CA) since birth (J. Lee et al., 2008b; Ng et al., 2002; 
Nykanen, et al., 2010; Sari et al., 2012).  Despite the evidence that postmenstrual age is 
important, only a small number of studies have examined adrenocorticoid values in 
premature infants at a common postmenstrual age, beyond the first two weeks after birth.   
Most studies have also used cross-sectional designs, although some exceptions are noted.  
In 1995, Al Saedi and colleagues conducted a longitudinal study in which weekly 
adrenocorticoid values were measured, up until 37 postmenstrual weeks of age, in infants 




were sampled, yielding the construction of reference ranges for cortisol and 17-OHP for 
premature infants from 30 to 37 postmenstrual weeks of age.  Arnold and colleagues also 
examined adrenocorticoid values longitudinally and developed their data relative to 
postmenstrual age (Arnold, et al., 1997).   In Arnold’s study, 26 premature infants 
(median gestational age 28 weeks) were followed to 16 weeks of age.  Infants were 
characterized as unwell (requiring mechanical ventilation, FiO2 >25%, or intravenous 
fluids) or well.  A total of 95 plasma cortisol and 78 plasma 17-OHP samples were 
collected, with progressive loss of weekly sample size throughout the investigation. 
Researchers concluded that plasma cortisol and 17-OHP levels were influenced by both 
postnatal and postmenstrual age.  Cortisol levels were not influenced by illness at any 
point; however 17-OHP levels were significantly higher in unwell infants between five 
and eight weeks of age.   
In 1999, Linder and colleagues measured 17-OHP values in a sample of 66 premature 
infants at eight points between birth and 90 days of age, and compared the results to birth 
samples of 100 term newborns (Linder et al., 1999).  Researchers identified that by 90 
days of age, for infants born at over 29 weeks of gestation, the average 17-OHP 
concentrations fell to those of the term infants.  For infants born at under 29 weeks of 
gestation, the concentration at 90 days of age was almost double that of full term infants.  
Only infants who were born at more than 33 weeks of gestation achieved term levels by 
60 days of age.  Researchers concluded that post-conceptual age was the most important 




In 2002, Weller and colleagues conducted a longitudinal study of 87 larger premature 
infants (1500-2000 grams) who were randomized to receive kangaroo care or 
conventional care after birth (Weller et al., 2002).  Thyroid hormone and 17-OHP values 
were measured at birth, two weeks of age, and at 41 postmenstrual weeks of age.  For all 
infants, the final measurement was obtained after discharge from the hospital.  Post-
discharge values were highly variable but approached normal full-term values at 41 
postmenstrual weeks of age, independent of whether kangaroo care was applied.  
Differences in adrenocorticoid profiles between small and average weight prematures has 
been explored.  In 1999, Heckmann and colleagues sampled 37 appropriate-for-
gestational-age (AGA) and 8 small-for-gestational-age (SGA) infants born at under 30 
weeks of gestation to identify resting serum cortisol values (Heckmann, Wudy, Haack, & 
Pohlandt, 1999).  Serum cortisol values were measured once during the first two weeks of 
age for each infant.  SGA infants were found to have significantly higher cortisol values 
compared to AGA infants.   
The evidence for differences in adrenocorticoid values between premature male and 
female infants is mixed.  While a number of researchers do not identify differences in 
adrenocorticoid values between male and female infants (Grunau, et al., 2007; Grunau et 
al., 2005; Heckmann, Wudy, Haack, & Pohlandt, 2000; Scott & Watterberg, 1995), some 
report otherwise.  In a sample of 38 preterm and 319 full term infants, Ballerini and 
colleagues found higher 17-OHP values in boys compared to girls during the first year of 
age, but no differences for cortisol (Ballerini et al., 2010).  More recently, Grunau and 




corrected conceptual age (CCA) in formerly  premature male infants compared to their 
female counterparts (Grunau, et al., 2010).   
Adrenocorticoid levels appear to be consistently impacted by SGA and IUGR in 
premature infants, although the direction of alteration is variable.  Disproportionately 
small size has been associated with both higher (Heckmann, et al., 1999) and lower 
(Doerr, Versmold, Bidlingmaier, & Sippell, 1989) cortisol values in premature infants, as 
well as various alterations in other HPA axis hormones (Doerr, et al., 1989; Ersch, et al., 
2008; Heckmann, et al., 1999).   
Studies examining the impact of antenatal and postnatal glucocorticoids on the neonatal 
HPA axis are well represented in the literature. There is consensus that antenatal 
glucocorticoid exposure has only a minimal effect on infant glucocorticoid levels after 
two weeks of age (Bolt et al., 2002b; Ersch, et al., 2008; Huysman, et al., 2000; Midgley, 
et al., 1998; Ng et al., 1999; Tegethoff, Pryce, & Meinlschmidt, 2009), and that they do 
not have prolonged impact on infant adrenocorticoid activity (Ng, et al., 2002; Ng, et al., 
1999).  The evidence is quite different for postnatally administered glucocorticoids.  
Numerous studies have found that postnatal glucocorticoid exposure significantly 
impacts infant adrenocorticoid activity.  Postnatal glucocorticoid exposure in premature 
infants is associated with lower basal cortisol levels during hospitalization (Bettendorf et 
al., 1998; Cole et al., 1999; Kari, Heinonen, Ikonen, Koivisto, & Raivio, 1993; Kari, 
Raivio, Stenman, & Voutilainen, 1996; Ng et al., 1997; Wittekind, et al., 1993).  In 




ongoing HPA axis suppression in long-term follow-up studies of premature infants 
(Glover, Miles, Matta, Modi, & Stevenson, 2005; Grunau, et al., 2007).   
There is also consensus in the literature that, in contrast to the circadian pattern reported 
in older children and adults, a free running rhythm is the hallmark of cortisol secretion in 
both premature and term neonates.  Circadian rhythms in the first three months of age 
have been found to be absent using both serum cortisol measures (Price, Close, & 
Fielding, 1983; Vermes, Dohanics, Toth, & Pongracz, 1980) and salivary cortisol 
measures (Price, et al., 1983).  In 1993, as part of a larger investigation, Economou and 
colleagues examined patterns of cortisol in sick term and sick premature infants, and 
compared them to well term and well premature infants (Economou, Andronikou, Challa, 
Cholevas, & Lapatsanis, 1993).  Sixty infants were sampled at six-hour intervals on days 
of age 1, 3, 5, 10, 15 and 30.  Researchers were unable to identify increases or decreases 
in cortisol within a 24 hour cycle in any of the groups of sick or well infants.    
Even in the absence of clear circadian patterns in young infants, there is a pulsatility 
feature of hormone secretion, whereby cortisol is secreted in 15 to 30 shorts bursts 
throughout the day (Metzger, Wright, Veldhuis, Rogol, & Kerrigan, 1993).  Low 
birthweight infants, however, show little variability in their plasma cortisol levels over 
time.  As such, random serum cortisol measurements have been proposed to be adequate 
in reflecting the adrenal status of these infants (Jett et al., 1997). 
Recently, with widespread use of 17-OHP in newborn state screening programs for 
congenital adrenal hyperplasia, there has been increased interest in explaining the 




infants, Ryckman and colleagues found that respiratory distress syndrome in premature 
infants was associated with higher 17-OHP, lower gestational age, and lower birthweight 
(Ryckman et al., 2012).  Authors proposed incorporating birthweight and gestational age 
data into the interpretation of 17-OHP values in infants to decrease the false positive rates 
of testing. 
Summary of neurologic development and the infant HPA system.  The HPA axis 
activates in response to stress, affecting the release of cortisol.  Cortisol reaches target 
tissues and stimulates hypertension, immunosuppression, glucose release, and other 
survival responses.  It would be difficult to thrive under these conditions if they were 
persistent over time.  The efficacy with which the chronically stressed organism promotes 
negative feedback is considered critical for survival.   
The literature examining adrenocorticoid values in infants is broad, and has generally 
evolved from characterization of the basal state and the stress response, to the 
examination of factors that alter these conditions.  The distribution of cortisol values in 
prematurely born infants is marked by low variability.  Cortisol values overlap between 
premature and term infants, between sick and well infants, and across a range of clinical 
diagnoses.  Adrenocorticoid data for premature infants is typically presented in terms of 
CA, and uncommonly according to postmenstrual age.  Postmenstrual age, however, has 
been found to impact the interpretation of these values.    
Cortisol levels do not always correlate well with their precursor levels.  Cortisol 
precursors may better represent stress responses in premature infants.  Because of its role 




commonly examined than other precursors in both premature and term infants. Premature 
infants generally have higher 17-OHP levels than term infants at similar postmenstrual 
ages.  Infants who have been exposed to chronic in-utero stress also appear to have 
elevated 17-OHP levels.  With widespread use of 17-OHP as a biomarker for congenital 
adrenal hyperplasia in newborns, there has been increased interest in explaining its 
variability in premature infants.   
Infants who have had restricted growth prior to birth have different adrenocorticoid 
phenotypes compared to appropriately grown infants.  It is less clear whether there are 
differences in phenotype between male and female infants.  Postnatal steroid exposure 
has consistently been shown to alter the adrenocorticoid phenotype, while the effect of 
prenatal adrenocorticoid exposure is transient.  In contrast to the circadian pattern found 
in children and adults, a free running rhythm is the hallmark of cortisol secretion in both 
premature and term infants in the first months after birth. 
Stress and Pain in Infancy 
Researchers have long been interested in the effect of stress on health and disease (Selye, 
1976; Selye & Horava, 1953).  Stress has been viewed from both psychological and 
biological perspectives.  From the biological perspective, stress is a term applied to 
physiologic and endocrinologic responses generated by some external stimuli (Wong, 
McIntosh, Menon, & Frank, 2003).  Stress has been defined as the nonspecific response 
of the body to any demand, and a stressor as the agent that produces that demand (Selye, 




demands on the organism.  These stressors include agents such as light, infection, 
hypoxia, noise, hemorrhage or pain.   
Pain, nociception and HPA activation.  Since Gunnar’s work in the 1980s, other 
researchers have demonstrated that the neonate experiences a physiologic response to 
presumably painful procedures, which can be described in terms of HPA activation 
(Anand & Hickey, 1987, 1992).  Numerous studies have described adrenocorticoid values 
in premature infants following such pain-associated exposures (Boyer, Johnston, Walker, 
Filion, & Sherrard, 2004; Cignacco, Denhaerynck, Nelle, Buhrer, & Engberg, 2009; 
Hughes et al., 1987).  These studies largely demonstrate that the infant mounts a 
hormonal stress response to skin-breaking procedures, and that while analgesia alters the 
behavioral responses to these procedures, the effect of analgesia is limited on the 
adrenocortical stress response (Boyer, et al., 2004; Franck, Ridout, Howard, Peters, & 
Honour, 2011; Grunau, et al., 2005; Stang, et al., 1988).  
Pain-associated procedures can be considered on a continuum of stressors that have 
varying impact on HPA activation (Grunau, et al., 2005).  In 2009, Gunnar and 
colleagues conducted a review of the literature to identify stressor paradigms used to 
produce HPA activation in pediatric research, as measured by mean elevations in salivary 
cortisol in (Gunnar, Talge, et al., 2009).  While handling and novel stimulation appeared 
to affect hormonal stress responses in certain groups of infants, minor skin-breaking 
procedures, such as blood draws and inoculations, were identified to most consistently 




identified in this review, 17 studies (94%) reported elevations in mean cortisol values 
with this stressor.  
There is a differentiation between pain and nociception in the literature.  Pain is typically 
defined with attention to the shared nature of this phenomenon as both sensory and 
emotional.  According to the International Association for the Study of Pain (IASP), pain 
is “an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or described in terms of such damage” (Loeser & Treede, 2008).  The 
AAP Neonatal Pain Control Group has addressed the inherent weakness of emotional or 
self-reported components as necessary conditions for pain, and has proposed that “the 
inability to communicate verbally or nonverbally does not negate the possibility that an 
individual is experiencing pain…” (Kanwaljeet et al., 2006).   
Because mature thalamocortical connection are not present until mid to late gestation, 
there is controversy as to whether the very premature infant can experience pain until 
then.  Pain requires both nociception and interpretation (Lowery et al., 2007).  
Nociception is a term used to describe the activation of nervous tissue by tissue damage, 
or the metabolic or neurobiological effects of a noxious stimulus, independent of any 
judgment of higher consciousness, memory, emotional effects or suffering (Wong, et al., 
2003).   Like the human response to pain, nociception is associated with an increase in 
catecholamines, cortisol, and other stress hormones.   
Procedure-associated stress responses are not necessarily the result of pain (Grunau, 
Holsti, & Peters, 2006).   It has been suggested that the lack of differentiation between 




be biologically important in the neonate (Anand & Hickey, 1987).   Several researchers 
suggest that physiologic responses to pain-associated stressors in premature infants 
should be described in terms of nociceptive activity, rather than in terms of pain, to avoid 
implicating an unexamined psychological experience  (Anand & Hickey, 1987; Simons & 
Tibboel, 2006).   
Procedural pain and pain-associated stressors.  In the absence of self-report, painful 
NICU stressors have been established through expert provider rating of procedural 
painfulness, and by using instruments that develop proxy pain scores from a composite of 
infant response measurements following various stimuli.  From these research efforts, a 
set of pain-associated stressors has been identified. 
In 2009, Cignacco and colleagues, as part of a larger study on the frequency of 
procedural pain in NICU, surveyed 431 NICU caregivers to identify perceived procedural 
painfulness and to establish a pain intensity rating for many of the routine procedures 
conducted in the NICU (Cignacco, Hamers, et al., 2009).   Using median pain intensity 
ratings for 27 acknowledged procedures, Cignacco identified that 70% were rated as 
painful, and 44% were judged as very painful by providers.  Among the very painful 
procedures identified by this study were thoracic drain insertion and removal, tracheal 
intubation, lumbar puncture, bladder puncture, peripheral intravenous catheter insertion, 
intramuscular injection, endotracheal suctioning, heel lance, and venipuncture.   
In 1999,  also as part of a larger pain study, Porter and colleagues attempted to define 
procedural painfulness by examining the relationship between clinician-perceived 




(Porter, Wolf, & Miller, 1999).  Significant correlation between clinician-perceived 
invasiveness/intensity and magnitude of infant response was identified for arterial 
puncture, venipuncture, heel lance, circumcision and eye examination.  Researchers 
found that there were considerable overlaps between perceived invasiveness gradations 
and concluded that there may not be an assessment threshold to clearly mark the presence 
of pain in infants.  In addition, inadequate distinction between the concepts of 
“invasiveness” and “painfulness” may have compromised the validity of study findings. 
Other studies have supported the measure of caretaker perceived painfulness.  In 2003, 
Dodds surveyed 21 NICU nurses and found strong agreement for the painfulness of 
infant thoracic drain insertion, circumcision, central venous catheter insertion, arterial 
catheter insertion, lumbar puncture, venipuncture, intramuscular injection, heel lance, 
tracheal intubation, and airway suction (Dodds, 2003).  In 2003, Rohrmeister and 
colleagues conducted a survey of pain practices in Austrian NICUs during which 
commonly performed NICU procedures were rated for perceived painfulness by 
respondents (Rohrmeister et al., 2003).  Heel lance, intramuscular injection, 
venipuncture, arterial and central line placement, and thoracic drain insertion were judged 
by over 90% of respondents to be painful.   
In the absence of an empirical way of assigning a pain intensity weight to painful 
exposures, Grunau operationalized NICU procedural pain exposure as the sum of a 
composite of skin-breaking procedures (Grunau, et al., 2004; Grunau et al., 2009).  
Furthermore, she suggested that this measure more likely reflected cumulative pain-




exposure (Grunau, et al., 2009).  The use of counting procedures as a marker for pain 
exposure, or as measurement of pain-related stress, has been used by other researchers as 
well (Holsti, Weinberg, Whitfield, & Grunau, 2007; Porter, et al., 1999; Stevens et al., 
2003). 
Difficulty in obtaining an accurate count of skin-breaking procedures is also described.  
In 2008, Carabjal and colleagues used direct observation techniques to examine exposure 
to painful procedures in NICU patients.  Researchers identified that over 35% of 
procedures performed were supplemental attempts at primary procedures, with some 
painful procedures needing as many as 10 to 15 attempts for completion.   
Pain and stress of assisted ventilation.  Mechanical ventilation is empirically 
recognized as a pain-associated stressor in the NICU (Anand et al., 1999; Aranda, et al., 
2005).  In their review of pain management for neonates receiving assisted ventilation, 
Hall, Boyle and Young noted that “assisted ventilation in neonates is presumed to be 
associated with chronic repetitive pain, which in turn is associated with adverse long-
term sequelae” (Hall, Boyle, & Young, 2007).   
Sick, premature infants often require assisted ventilation for prolonged periods of time.  
Several studies in older children and adults have supported this experience as stressful 
(Granja et al., 2005; Grossbach, Chlan, & Tracy, 2011; Novaes et al., 1999; Tracy & 
Chlan, 2011),  but few have examined assisted ventilation as a pain-associated stressor in 
premature infants.   
It has been suggested that this gap in evidence is related to the lack of validated pain 




in measuring pain during mechanical ventilation in premature infants was noted by 
Anand and colleagues during the NEOPAIN (Neurological Outcomes and Pre-emptive 
Analgesia in Neonates) Multicenter Trial (Anand et al., 2004; Boyle, Freer, Wong, 
McIntosh, & Anand, 2006).  The goal of this trial was to understand whether morphine 
analgesia decreased the rate of death or significant neurologic events in preterm infants.  
As part of this study, factors that could be useful in assessing persistent pain in premature 
infants who were receiving mechanical ventilation were examined.  These factors 
included general activity, response to handling, respiratory effort, ventilator synchrony, 
resting posture, quality of spontaneous movements, blood pressure and heart rate, amount 
of sleep, and response to noise.  Problems in differentiating between acute pain and 
persistent pain were identified, with nearly one-third of nursing assessments incorrectly 
identifying whether or not an infant subject was randomized to analgesia. Researchers 
recommended an interim approach of presuming that mechanical ventilation was 
nevertheless painful and distressing, while persisting in the investigation of analgesic 
approaches for premature infants receiving this therapy.  
In 1992, Quinn and colleagues examined the effect of morphine and pancuronium on 
noradrenaline stress responses in ventilated premature infants (Quinn et al., 1992).  While 
the study was limited by subject withdrawal, morphine was demonstrated to reduce 
overall noradrenaline levels compared with pancuronium.  Researchers concluded that, 
compared to paralysis, analgesia may have attenuated the stress of NICU care.   
Despite lack of validation of assisted ventilation per se as painful, the ongoing procedures 




intubation, have been recognized as painful (Cignacco et al., 2008; Porter, et al., 1997; 
Porter, et al., 1999).  In addition, to further complicate its examination as an independent 
variable, measures of exposure to assisted ventilation have been found to be collinear 
with other infant variables, such as gestational age and  birthweight (Grunau, et al., 2007; 
Grunau, et al., 2010; Grunau, et al., 2004; Yamada et al., 2007).   
In 2007, Yamada and colleagues examined the association between hair cortisol values 
and illness in infants who had received NICU care to determine if hair cortisol could be a 
surrogate measure for cumulative stress (Yamada, et al., 2007).  Cumulative stress was 
measured in terms of days of mechanical ventilation.  Researchers did not find significant 
differences in hair cortisol values between premature and term infants, however identified 
a statistically significant correlation between hair cortisol values and days of assisted 
ventilation.  While this study was limited by recruitment difficulties and a lack of 
sufficient hair samples in several subjects, results supported the examination of hair 
cortisol as a potential biomarker for cumulative stress.   
Accumulation of pain-associated NICU stress.  Advancement in NICU survival 
generally entails the need for a greater number diagnostic and therapeutic procedures, and 
greater exposure to assisted ventilation (Lorenz, Paneth, Jetton, den Ouden, & Tyson, 
2001).  Consequently, the early experience of premature infants is markedly different 
from that of normal newborns.  The reasons for these differences have been summarized 
as repeated procedural exposures, tissue damage related to surgery, and invasive devises 
used in mechanical ventilation (Kanwaljeet, et al., 2006). 




hundreds of pain-associated procedures during their initial hospitalization, with the 
highest exposures in the youngest, smallest and most vulnerable patients (D. P. Barker & 
Rutter, 1995; Carbajal et al., 2008; Cignacco, Hamers, et al., 2009).   
Distinguishing stress response from pain response was an interest of Holsti and 
colleagues in 2005 (Holsti, Grunau, Oberlander, Whitfield, & Weinberg, 2005).  In 
addition, these researchers were interested in examining the impact of prior pain on infant 
responses.  In a sample of 54 premature infants at 32 postmenstrual weeks of age, 
behavioral and physiologic responses to heelstick (pain) and clustered care (stress) were 
measured and compared.  Researchers identified that changes in facial activity and heart 
rate were the most sensitive indicators of pain in premature infants, and that facial 
activity became diminished after recurrent prior pain exposure.  Both changes in facial 
activity and heart rate occurred with stress, although these changes were less intense and 
more protracted.    
In 2009, Newnham and colleagues set out to develop a tool to measure cumulative infant 
stress based upon the presumptions of health care providers (Newnham, Inder, & 
Milgrom, 2009).  Using survey methods, 137 nurses and doctors used a Likert scale to 
rate the stressfulness of acute activities and chronic living conditions for premature 
infants.  In addition, respondents rated the stressfulness of acute activities for the 
provider.  Individual responses ranged across the five-point-scale for nearly all items.  
Researchers found that nearly all of the acute events were perceived as moderately, very, 
or extremely stressful for infants of all gestational ages.  Skin-breaking procedures were 




were also judged to be at least a little or moderately stressful by respondents.  Many 
individual items were correlated with clinician’s own stress perception, notably gavage 
feeding at all gestational ages and breast feeding at older gestational ages.  The scale was 
not validated with any physiologic measures of stress.  It was also not clear how 
researchers chose items for the survey.  Conditions known in the literature to be 
associated with endocrinologic stress responses, such as temperature instability, maternal 
separation, and light/noise exposure were not specifically included among the items in 
the survey.  Newnham’s work reveals some of the difficulties in measuring cumulative 
stress in the premature infant population, such as construct validity and high response 
variability.  
Summary of stress and pain in early life.  In an examination of stressor paradigms that 
produce cortisol elevations, skin-breaking procedures have been identified as most 
effective in causing immediate elevations in mean cortisol in infants.  Skin-breaking 
procedures and procedures associated with assisted ventilation are recognized as painful 
and stressful for infants cared for in the NICU.  Premature infants may undergo hundreds 
of painful procedures during their initial hospitalization.  Proxy assessment methods have 
been developed to measure painful and stressful conditions and procedures in the NICU, 
although these measurements have limited validity.   
Pain requires both nociception and interpretation.  Mature thalamocortical connections 
are not present until mid to late gestation, which has led some researchers to believe that 
very premature infants do not experience pain until then.  Nociception, however, is 




recognize that the procedure-associated stress response in premature infants is not 
necessarily the result of pain.  Researchers caution that physiologic responses to skin-
breaking procedures in premature infants should therefore not ordinarily be described as 
painful.  Some evidence suggests that there are differences in bodily movements between 
infants who are experiencing stress and pain, although this has not been validated using 
hormonal measures. 
Perinatal Events, Stress Adaptation and Developmental Sequelae 
Prematurity is a major public health problem in the United States, contributing 
substantially both to infant mortality and to childhood disability. Infants born with low 
birthweight account for nearly seventy percent of infant deaths (Heron et al., 2010).  In 
addition, premature birth is an important factor in lifelong disability.  An estimated 50 to 
70 percent of infants weighing under 1500 grams at birth will have long-term disabilities 
(Aylward, 2003).  The increasing capacity of neonatal intensive care has resulted in a 
demographic shift from neonatal death to infant survival (Mathews, MacDorman, & 
MacDorman, 2008) with a corresponding escalation in the prevalence of  prematurity-
associated disability (Wilson-Costello, Friedman, Minich, Fanaroff, & Hack, 2005).   
Premature birth has long been associated with motor impairment, academic achievement 
difficulties, psychological and emotional issues, and attention and behavioral problems 
(P. Anderson & Doyle, 2003; P. J. Anderson & Doyle, 2008; Botting, Powls, Cooke, & 
Marlow, 1997, 1998; Edwards et al., 2011; Hack et al., 2002; Hack et al., 2005; S Saigal 
et al., 1994; S. Saigal, Rosenbaum, Szatmari, & Campbell, 1991; S. Saigal, Szatmari, 




Rosenbaum, Campbell, & King, 1990; Whitfield, Grunau, & Holsti, 1997; Winchester et 
al., 2009).  Survivors of premature birth have also been identified with more subtle 
neurobehavioral sequelae, including difficulties with executive functions, self-regulation, 
temperament, pain sensitivity, arousal and social interaction, as well as disorders of 
growth (Aarnoudse-Moens, Weisglas-Kuperus, van Goudoever, & Oosterlaan, 2009; P. 
Anderson & Doyle, 2003; Grunau, Whitfield, & Petrie, 1994; Jongbloed-Pereboom, 
Janssen, Steenbergen, & Nijhuis-van der Sanden, 2012; McGrath et al., 2005; Sullivan, 
McGrath, Hawes, & Lester, 2008).   
Medical complications during the perinatal period seem to account for only a moderate 
amount of variance in developmental outcomes for premature infants (Aarnoudse-Moens, 
Smidts, Oosterlaan, Duivenvoorden, & Weisglas-Kuperus, 2009; Johnson, Wolke, 
Hennessy, & Marlow, 2011; van Baar, Vermaas, Knots, de Kleine, & Soons, 2009).  A 
shift in attention from methods aimed at supporting neonatal survival to those aimed at 
identifying and modifying the multiple factors that may contribute to altered 
neurobehavioral outcomes and lifelong disability is accordingly identified in the 
literature.   
Adverse early life events and developmental sequelae.  Above the impact of 
prematurity, exposure to early life stress is being increasingly recognized as a factor that 
negatively affects developmental outcomes. Fetal exposure to intrauterine stress marked 
by IUGR and low birthweight, has been associated with a constellation of diseases and 
disabilities in later life.  Independent of prematurity, IUGR and intrauterine stress have 




glucose intolerance and non-insulin dependent diabetes mellitus (D. J. Barker, 2002; 
Henry et al., 2011; Thompson & Regnault, 2011; Zhang, 2005).   
Like IUGR, poor postnatal growth has been used as a proxy for an adverse infant 
environment (Phillips & Jones, 2006). Poor postnatal growth has been associated with 
impaired neurocognitive development (Ehrenkranz et al., 2006; Latal-Hajnal, von 
Siebenthal, Kovari, Bucher, & Largo, 2003; Stephens et al., 2009).  Infants with neonatal 
morbidities tend to regain birth weight later.  Researchers have reported an association 
between slower growth rates in extremely premature infants in the NICU and adverse 
long-term neurodevelopmental outcomes (Franz et al., 2009).  
Pain exposure in the NICU has been proposed as another specific stressor that contributes 
to neurodevelopmental alterations in this population (Anand, 2000; Grunau, 2002; 
Grunau, et al., 2006) although only one human study has been identified in which this 
hypothesis was tested.  In 2009, Grunau and colleagues examined Bayley developmental 
scores from 116 premature at 8 and/or 18 months of age as part of a larger longitudinal 
study (Grunau, et al., 2009).  Retrospective chart review was used to develop a count of 
pain-associated NICU procedures and days of assisted ventilation.  Researchers identified 
a relationship between high procedural pain exposure and impaired cognitive and motor 
function at 8 and 18 months of age.  Collinearity between predictor variables made it 
difficult to examine the independent effect of pain exposure on neurodevelopment, 
although gestational age at birth was not associated with either cognitive or motor 




exposure.  Researchers speculated that neonatal pain and ventilation exposure was a more 
specific indicator for neurodevelopmental outcome than gestational age at birth.    
Adrenocorticoid adaptations and developmental sequelae.   Early life elevations in 
allostatic load have been postulated to impact stress adaptation, thereby increasing 
vulnerability to certain physical diseases and psychosocial disorders (Gunnar, Frenn, et 
al., 2009; S. M. Korte, et al., 2005; Lupien, et al., 2009; McEwen, 2001; McEwen & 
Wingfield, 2003).  
The Developmental Origins Theory has been the basis for numerous studies, proposing 
that early stress provokes adaptive changes in endocrine processes that impact later health 
(D. J. Barker, 2007; D. J. Barker, Eriksson, Forsen, & Osmond, 2002).   In an extension 
of this theory, adrenocorticoid alterations associated with infant stress, such as those 
which results from an adverse perinatal environment, have been proposed as the 
mechanism underlying many of the chronic diseases and disabilities in low birth weight 
survivors (Sullivan, Hawes, et al., 2008).   
Studies are beginning to test this extension of the Developmental Origins Theory.  In 
2006, Haley and colleagues examined infant learning in relation to basal and stress 
cortisol levels in premature and term infants who were three months CCA (Haley, et al., 
2006).  Researchers identified that premature infants had lower cortisol levels and smaller 
cortisol responses than full-term infants, and that even when corrected for prematurity, 
lower cortisol was associated with poorer memory for accomplishing a mobile task. 
In another application, researchers demonstrated that the rate of catch-up growth in IUGR 




Germani, 2002).  After examining the cortisol profiles of 49 IUGR children, Cianfarani 
and colleagues identified that poor catch-up growth in IUGR children was associated 
with higher concentrations of serum cortisol in childhood.  They postulated that 
intrauterine reprogramming of the HPA axis resulted in modification of the 
adrenocorticoid response to stress, thereby impacting postnatal growth rates of IUGR 
children. 
In 2004, Hofman and Cutfield  examined 72 children and identified that those who were 
born prematurely had reduced insulin sensitivity patterns similar to the patterns seen in 
SGA, term-born children  (Hofman et al., 2004).  Prematurely born infants who were 
AGA and SGA did not, however, have significant differences in insulin sensitivity.  
Researchers concluded that, like growth restricted term infants, children who are born 
prematurely have adrenocortical adaptations resulting in reduced insulin sensitivity in 
childhood, which may be a risk factor for type 2 diabetes mellitus. 
Summary of perinatal events, stress adaptation and developmental sequelae.  
Premature delivery affects approximately 12% of all births in the United States and is a 
leading cause of death and disability among children.  Premature birth is associated with 
lifetime cognitive, emotional and physical disabilities.  The degree of lifetime disability 
experienced by premature infants, however, appears to be disproportionate to their 
experience of medical complications.   
A growing body of literature supports the association of early life stress with the 
development of subsequent disease.  HPA axis adaptations associated with early life 




adversity and adult disease.  HPA axis adaptations associated with NICU care are also 
being proposed as a mechanism underlying many of the diseases and disabilities in 
survivors of prematurity.   
Pain-Associated NICU Stress and the Adrenocorticoid Phenotype  
Five studies have been identified that examine the relationship between adrenocorticoid 
values and cumulative pain-associated procedural exposure in infants who have been 
cared for in the NICU.  These studies, which looked at premature infants during NICU 
hospitalization and in their early months following discharge, were all conducted under 
the direction of the Canadian researchers, Grunau and Holsti.   
NICU Studies.  Two studies examining adrenocorticoid function in premature infants 
within the NICU are identified.  The results from the first of these studies suggests that 
high cumulative exposure to painful stressors predicts dampened adrenocortical reactivity 
at 32 postmenstrual weeks of age in infants who are born at the lowest gestational ages.  
The other study demonstrates that recent exposure to painful stressors (within 24 hours) 
is associated with elevated resting adrenocorticoid activity.   
In 2005, Grunau and colleagues examined the relationships between cumulative painful 
exposures, morphine exposure and subsequent physiologic, behavioral and 
adrenocorticoid responses to pain and stress in premature infants (Grunau, et al., 2005).  
Eighty-seven premature infants who had not been exposed to postnatal corticosteroids 
were studied at 32 post-conceptual weeks of age.  Infant responses to heel lance (pain) 
and to clustered nursing care (stress) were examined in a repeated measures randomized 




at birth) and later born (29-32 weeks of gestation at birth) infants.  Cumulative painful 
exposures were defined as the total number of skin breaking procedures since birth, 
including heel lance, venipuncture, arterial or venous line insertion, lumbar puncture and 
thoracotomy.  Researchers identified that higher cumulative pain was significantly 
negatively correlated with cortisol reactivity and facial activity to handling stress in the 
younger gestational age group, but not in the older gestational age group. Researchers 
postulated that there may be a “cutoff” of stressful exposures that must be reached before 
seeing dampened cortisol reactivity.  Researchers also identified that morphine exposure 
was not related to cortisol response.  After adjusting for illness severity, higher 
cumulative painful exposures also predicted lower cortisol reactivity to handling stress in 
the earlier-born premature infants.  Regression analysis was limited by multicollinearity:  
the number of skin-breaking procedures in NICU was highly correlated with gestational 
age, birthweight, illness severity, and number of days of mechanical ventilation.   
In 2007, Holsti and colleagues examined adrenocorticoid values (ACTH and cortisol) at 
rest, as well as adrenocorticoid values and facial activity in response to clustered nursing 
care, in a sample of 90 premature infants at 32 post-conceptual weeks of age using a 
within subjects crossover design (Holsti, et al., 2007).  Comparisons were again made 
between earlier born (<28 weeks of gestation at birth) and later born (29-32 weeks of 
gestation at birth) infants.  Researchers failed to identify differences in resting or stress 
adrenocorticoid values between earlier-born and later-born infants and concomitantly 
between those with higher and lower cumulative pain exposure.  A higher number of 
recent skin breaking procedures (within 24 hours) was correlated with elevated resting 




hormones and identified a correlation between stress ACTH and cortisol in the older 
infants, but no relationship between stress values in the younger gestational age group, or 
between resting values in either age group.  Facial responses to handling were dissociated 
from hormone values in both groups.  Researchers speculated that basal hormone values 
remain relatively well preserved in the first few weeks of age, and that the lack of change 
in the relationship between ACTH and cortisol under stress conditions in the younger 
gestational age group might represent an early neuroprotective adaptation in infants 
exposed to greater cumulative stress. 
NICU follow-up studies.   Three studies were identified in which the relationship 
between stressful NICU exposures and adrenocorticoid activity in the first months of age 
following NICU discharge in prematurely born infants was examined.  While studies 
were limited by multicollinearity, salivary sampling issues, and participant withdrawal, 
researchers in two of these studies identified that cumulative exposure to skin-breaking 
procedures and mechanical ventilation in the NICU were important predictors of 
adrenocorticoid alterations in the early months following NICU discharge.  
In 2004, Grunau and colleagues used a cross sectional design to examine the relationship 
between the incidence of painful procedures and morphine exposure in NICU and basal 
cortisol values and cortisol responsivity to visual novelty at 8 months CCA (Grunau, et 
al., 2004).  Cortisol outcomes from earlier born premature infants (<28 weeks of 
gestation at birth) and later born premature infants (29-32 weeks of gestation at birth) 
were compared to the cortisol outcomes of full term infants.  Salivary cortisol values 




toy (basal), 20 minutes after introduction of the toy (post 1), and 30-40 minutes after 
introduction of the toy and following developmental assessment (post 2).  Researchers 
identified that earlier-born premature infants had significantly higher cortisol at all phases 
than later-born premature infants or full-term controls, and that the pattern of cortisol 
response differed significantly between earlier-born premature infants (a drop, rather than 
an increase, in cortisol from post 1 to post 2) compared to later-born premature infants 
and the controls.  Basal cortisol values in premature infants overall were significantly 
correlated to days on oxygen, gestational age at birth, and the number of skin breaking 
procedures in NICU.  Morphine exposure was not associated with cortisol values in any 
phase.  After controlling for early illness and days on oxygen, a higher number of skin 
breaking procedures independently predicted basal and post 1 cortisol at 8 months CCA.  
Gestational age, days of mechanical ventilation and number of skin breaking procedures 
were highly correlated, so researchers repeated the analysis using gestational age as the 
predictor.  After controlling for early illness and days on oxygen, gestational age was not 
related to basal cortisol at 8 months CCA in the premature infants, although it was 
associated with post 1 cortisol to the same extent as number of skin-breaking procedures. 
Researchers concluded that early pain exposure predicted basal cortisol values at 8 
months CCA, and that cortisol reactivity at this age was equally well predicted by early 
pain exposure and gestational age.   
In 2007, Grunau examined salivary cortisol values at 3, 6, 8 and 18 months CCA in 
earlier born premature infants (<28 weeks of gestation at birth) and later born premature 
infants (29-32 weeks of gestation at birth), and compared cortisol outcomes to those of 




discharge (Grunau, et al., 2007).  Using a cross-sectional design with retrospective NICU 
chart review, salivary cortisol was examined in a sample of 225 infants (145 preterm, 80 
term).  Researchers identified that at three months CCA, cortisol values were 
significantly lower in premature infants compared to term infants.  At 6 months there 
were no differences among the groups.  At 8 and 18 months, earlier-born premature 
infants had higher basal cortisol values when compared to later-born premature infants or 
term infants.  At 18 months, basal cortisol values were significantly correlated with 
gestational age, number of days of mechanical ventilation, and higher number of skin 
breaking procedures in the NICU.  Multicollinearity between the number of skin breaking 
procedures, days of mechanical ventilation, and gestational age at birth limited analyses, 
and researchers were unable to examine the independent relationship between these 
factors and cortisol.  In addition, researchers identified that they were unable to isolate 
pain-related stress from the stress of mechanical ventilation.   
In 2010, Grunau and colleagues examined salivary cortisol, facial actions and heart rate 
with immunization at approximately four months CCA in earlier born premature infants 
(<28 weeks of gestation at birth) and later born premature infants (29-32 weeks of 
gestation at birth), and made comparisons with full term infants, to identify patterns of 
pain response following NICU discharge.  A total of 138 infants (99 preterm, 39 term) 
had salivary samples collected at three points during a nurse home immunization visit: 
before vaccinations (basal), 20 minutes after injection (reactivity) and 30 minutes after 
injection (recovery).  With regard to cortisol, there were significant changes for all 
groups across events.  Researchers also identified that premature boys had lower overall 




have been confounded by post-NICU surgery, which was carried out on 7 boys (6 
premature, 1 term) and no girls.  No significant differences between boys and girls were 
identified for number of skin breaking procedures in the NICU, days of mechanical 
ventilation, or early illness severity.  Researchers concluded that premature infants have 
altered adrenocorticoid activity during immunization compared to term infants, but that 
these differences were not exaggerated in premature infants who were younger, sicker or 
exposed to more skin-breaking procedures in the NICU.   
Summary of pain-associated NICU stress and adrenocorticoid phenotype.   Many 
studies implicate NICU care as an adverse early life experience with enduring impact, 
although few have measured this adversity and studied it in relation to adrenocorticoid 
consequence.  Research is beginning to demonstrate a relationship between the incidence 
of exposures to pain-associated procedures during the NICU care and HPA axis 
adaptations in premature infants. 
Both cortisol resistance and cortisol sensitivity have been found in relation to NICU care.  
High exposure to pain-associated procedures appears to be associated with dampened 
cortisol reactivity at 32 post-conceptual weeks of age in infants who are born at the 
lowest gestational ages.  At four months CCA, premature infants appear to have lower 
cortisol levels than term controls, and then go on to develop elevated resting cortisol 
levels between 8 and 18 months of age. Male infants who are born at the lowest 
gestational ages may have different cortisol patterns than their female counterparts, as 




Most of the studies examining relationships between pain-associated NICU stressors and 
adrenocorticoid values have been limited by multicollinearity.  The number of stressor 
exposures in NICU is highly correlated with gestational age, birthweight, illness severity, 
and number of days of mechanical ventilation, making it difficult to identify the 
independent effect of each of these factors on the adrenocorticoid phenotype.   
Overall Summary 
Stress has been associated with alterations in long-term psychological, social and 
physical functioning and in the development of disease and disability.  Cortisol appears to 
be an important factor in the relationship between stress exposure and subsequent disease 
and disability.  NICU stressor exposure presents as a plausible explanation for HPA axis 
adaptation and some of the neurodevelopmental disability found in children who were 
born prematurely.    
The study of pain and stress in infancy dates back many decades.  The distribution of 
cortisol and cortisol precursor values at many postmenstrual and postconceptual ages is 
now partially described.  Our understanding has also evolved from an early view that 
infants were unable to perceive pain, to current acceptance that exposure to painful 
stimuli in infancy affects short-term behavioral, physiologic and endocrinologic 
outcomes.  In addition, pain-associated procedural exposure in infancy is currently being 
examined as a risk factor for adverse long-term neurodevelopmental outcomes in 
children.   
There remains much to be learned about the early developmental trajectory of 




on this trajectory.  Little is known of the evolution of HPA axis adaptations in premature 
infants in relation to their exposure to recurrent or prolonged pain-associated stressors, 
such as skin breaking procedures and assisted ventilation.   Both cortisol resistance and 
cortisol sensitivity have been identified in prematurely born infants during their first year 
of age.  It is hypothesized that altered cortisol phenotypes begin to emerge even earlier, 
and in relation to pain-associated stressor exposure.  Two studies have been identified 
that examined this relationship at 32 post-conceptual weeks of age, and three studies have 
been identified that examined this relationship at between four and 18 months CCA.  The 
approximate six month period between 32 post-conceptual weeks of age and four months 




CHAPTER 3: Methods 
Overview  
A descriptive, cross-sectional design was proposed to examine the association between 
recurrent exposure to pain-associated procedures, hours of assisted ventilation, and 
random cortisol values at 37 postmenstrual weeks of age in a sample of infants who were 
born prematurely and received care from birth in the NICU.   Cortisol is a well-
understood and commonly measured hormone in the clinical setting, and is relatively 
inexpensive to analyze.  Because there was concern that random cortisol values would 
not adequately reflect exposure to the multiple stressful stimuli, the exploration of 
associations between recurrent exposure to pain-associated procedures, hours of assisted 
ventilation, and random17-OHP values at 37 postmenstrual weeks of age was also 
conducted.  As previously indicated, the examination of 17-OHP as a potential stress 
biomarker capitalized on an opportunity to use a ordinarily present piece of infant clinical 
data – 17-OHP levels drawn after birth for congenital adrenal hyperplasia screening – in 
another way.  
Operational Definitions 
















Term Operational Definition 
Infant A live born fetus from birth through the first year of age. 
Neonate An infant in the first 28 days after birth.  For this study, neonates 
are included when referring to infants in the study sample.  
Premature Infant A fetus born at less than 37 completed weeks of gestation. 
Gestational Age (GA) The age of a fetus, expressed in completed weeks, calculated 
from the first day of the last normal menstrual period until the 
day of delivery. 
Chronological Age (CA) The time elapsed since birth, described in terms of days, weeks, 
months or years (also known as “postnatal age”). 
Postmenstrual Age 
(PMA) 




The age of a premature infant from the expected date of delivery; 
it is the chronological age reduced by the number of weeks born 
before 40 weeks of gestation. 
Neonatal Intensive Care 
Unit (NICU) 
An inpatient hospital care unit specializing in complex care of ill 
or premature infants, usually from birth through hospital 
discharge.   
Clustered Care An approach to nursing care where all “hands on” caregiving 
activities (diapering, feeding, suctioning, repositioning, etc.) are 
conducted in quick sequence, allowing for an extended period of 
patient rest before repeating the caregiving activities. 
Medical Record An account of a patient’s history, care activities and test results 
in a particular health care setting, including both electronic and 
physical forms of documentation. 
Medical Record 
Encounter 
Within the medical record, a discrete subset of documentations 
related to a specific patient visit or event. 
Assisted Ventilation The use of mechanical or other devices to help maintain or 
supplement spontaneous breathing.   
Medical Team A multidisciplinary group of health care provider responsible for 
a patient’s medical care. 
 
Heel Lance A method for blood sampling in infants whereby a lancet is used 




The department of a hospital where biological samples are 
received from patient care areas, prepared, and distributed to 






The study was conducted at a university-affiliated Level III, 46-bed NICU in Suffolk 
County, New York.  The NICU has approximately 1000 admissions annually, of which 
typically one-third are related to prematurity.  The NICU is a tertiary care center, 
employs neonatal nurse practitioners, and provides training for pediatric residents and 
neonatal fellows.  The NICU was renovated in 2011 to enhance provision of family-
centered care.  This included the establishment of single-patient rooms and elimination of 
twin co-bedding, which allowed for a measure of control of environmental disturbances 
to premature infants.  For example, infant exposure to noise and light are minimized 
under this arrangement.  In addition, there are no outside windows in the designated 
NICU setting that could impose variations in lighting in the patient care areas.   
Premature infants in this NICU receive blood sample analysis on at least a weekly basis.   
Subjects  
Sixty infants were recruited for this study.  Infants who had been admitted to the NICU 
within 24 hours of birth, who were under 35 completed weeks of gestation at birth, and 
who had received care in the NICU for a minimum of two weeks were eligible for 
inclusion.   
Several exclusionary criteria were identified to remove from this study those situations 
already established as influencing adrenocorticoid values.  These exclusionary criteria 
included infant diagnosis with a major endocrinologic disorder or a major congenital 
anomaly, the presence of IUGR, prolonged administration of postnatal systemic 




excluded if there was incomplete medical record data, such as resulting from a temporary 
inter-institutional transfer. 
Diagnosis with a major endocrinologic disorder or a major congenital anomaly was 
included as an exclusionary criterion to ensure control for the influence of intrinsic 
disease on adrenocorticoid values and is commonly exclusionary in studies examining 
cortisol activity in infants.   
The presence of IUGR was also exclusionary criterion, as IUGR has been identified to 
influence adrenocorticoid values in infancy.   In the absence of direct prenatal 
measurements of intrauterine growth, the diagnosis of a newborn as SGA has suggested 
the presence IUGR (Ogundipe, Wolfe, Seed, & Gamsu, 2000).  IUGR was considered to 
be present if an infant’s weight at birth was below the 10th percentile for gestational age 
based upon the Fenton growth curves (Fenton, 2003).   
Prolonged administration of postnatal systemic glucocorticoids has been reported to alter 
resting cortisol values in premature infants before the 37
th
 postmenstrual week of age and 
was therefore exclusionary criterion.  Prolonged systemic glucocorticoid administration 
was defined as the use of intravenous or enteric glucocorticoids (but not inhaled 
glucocorticoids) for a continuous period of greater than 48 hours prior to cortisol 
measurement during the 37
th
 postmenstrual week of age.   
Major surgical procedures often involve numerous discrete procedures such as 
endotracheal intubation, skin punctures and injections, and suture placements.  A count of 
these individual procedures would have been extremely difficult to obtain given the 




surgical procedure into a single pain-associated event was not felt to correctly represent 
such an event.  Common surgical procedures such as hernia repair, shunt or tracheostomy 
placement, and bowel re-anastomosis are commonly deferred until late in a premature 
infant’s NICU course, and have been associated with short term alterations in hormonal 
stress responsivity. This potentially affects measured adrenocorticoid values in the 37
th
 
postmenstrual week of age.  For these reasons, the decision was made to include major 
surgical procedures as an exclusionary criterion.  A major surgical procedure was defined 
as one in which the infant was transferred to the operating room and received general 
anesthesia.   
Incomplete medical record data precluded collection of pertinent information. In 
particular, this was true of infants who were treated in another facility for greater than 24 
hours at any time prior to cortisol measurement. Such infants were not eligible for 
recruitment into this study.  
Procedures 
Subject identification.  The investigator met with a NICU charge nurse weekly to 
review the census and identify newly admitted premature infants.  As all infants who 
were eligible for study inclusion were to be receiving care in the NICU for a minimum of 
two weeks, this one-week interval supported enough time to identify and obtain consent 
from all potential subjects without burdening the NICU charge nurse with recurrent 
review.   
Upon identification of a potential subject, a brief review of charted admission 




When the potential premature infant subject reached the end of the 36
th
 postmenstrual 
week of age, a brief review of the medical record was again conducted to identify any 
exclusionary criteria.  After this review, for infants who met criteria for study inclusion, 
the investigator approached a parent and requested consent for infant enrollment into the 
study.   A recruitment log (compliant with preparatory to research HIPAA standards) was 
maintained to keep track of participant enrollment.   
Data collection.  During the 37
th
 postmenstrual week of age, following study enrollment, 
the investigator communicated with the primary medical team and ascertained plans for 
routine laboratory testing of each infant subject.  Arrangements were then made to have 
the study samples drawn by the nursing staff in conjunction with routine labs.    
Data for the derivation of measures of recurrent exposure to pain-associated procedures, 
recent exposure to pain-associated procedures, and hours of assisted ventilation were 
obtained through a complete chart audit by the researcher in the week following blood 
collection for the measurement of cortisol and 17-OHP values at 37 postmenstrual weeks 
of age.  Data was recorded on a data collection sheet (Appendix A) prior to entry into the 
IBM SPSS Statistics 19 software program (Release 19.0; August, 2010) which was used 
for all data analysis procedures.  
Blood collection.  Identification of the 37
th
 postmenstrual week of age was calculated 
from the gestational age, as previously described, and recorded on the data collection 
sheet.  The investigator coordinated blood sampling for cortisol and 17-OHP values 
during this week so that it was aligned with routine blood sampling to minimize patient 




related labs, to improve likelihood that the values obtained were random.  Time of day 
for sample collections was not specified.  Circadian rhythms have not been conclusively 
demonstrated as present in neonates and so time was not expected to modify study 
results.   
Blood collection using heel lance or vessel puncture was done at the beginning of 
clustered care interventions.  Consistent with previous research (Holsti, et al., 2007), it 
was  assured that the infant had at least 30 minutes of undisturbed rest prior to laboratory 
sampling.  The process of performing laboratory testing at the beginning of clustered care 
interventions and after a 30 minute period of undisturbed rest was reviewed by the 
investigator at the beginning of the shift with each nurse who was to be drawing blood, 
and the investigator made episodic observations of the infants during this 30-minute 
period to assure compliance with the period of undisturbed rest.  Single-patient rooms 
facilitated minimization of noise and light during this rest period.   
Blood handling.  At the time of routine blood sampling, an additional single aliquot of 
infant blood totaling two milliliters was collected in additive-free, green-topped micro-
containers by the infant’s nurse.  Blood samples were labeled by the collector in 
accordance with policy, and either given to the investigator or forwarded directly by the 
nurse to Stony Brook Hospital’s specimen receiving department.  There, blood samples 
were centrifuged by laboratory staff to separate serum.  Serum was transferred into 
appropriate transport tubes and expressed shipped by the specimen receiving department 
to ARUP National Reference Laboratories (www.aruplab.com), at a temperature of 2-




A separate medical record research encounter was generated for each subject for ordering 
and reporting the results of blood specimens, as is customary for the separation of the 
clinical record and the research record.  This separate encounter also assured that there 
was no cost to the patient or to his/her payor for participation in this research.  Laboratory 
costs generated under the research encounter were billed directly to an account funded by 
the investigators. Laboratory results generated by the research are in this way also made 
discoverable by the infant’s health care providers.  
For problems related to laboratory error or specimen handling issues in the measurement 
of cortisol and 17-OHP, there was an opportunity to repeat testing if another routine 
blood sample was indicated for the infant within the 37
th
 postmenstrual week of age. 
Arrangements were made with the specimen receiving department and with ARUP to 
report such problems as soon as possible to the investigator, using email or cellular 

















Staff instruction and support.  As resources for their role in clinical investigations, 
bedside nursing staff in the NICU received the support of two NICU nurse educators and 
the investigator.  Nurse educators were available to provide shift-based support for 
protocol adherence, and were prepared to assist in problem-solving with the staff.  NICU 
staff members are additionally required to be certified in the responsible conduct of 
research and had consequently received education on human subjects protection and 
research compliance through the Collaborative Institutional Training Initiative 
(www.citiprogram.org).  
Consistent blood sampling procedures and comprehensive documentation by NICU staff 
members was necessary to ascertain the validity and reliability of study results.  The 
investigator provided instruction to staff regarding the study purpose and protocols, and 
provided both in-person and on-call support for protocol adherence.  To address staff 
questions or concerns when drawing blood samples, the investigator was available by 
cellular phone when not available to address these issues in person.  The research study 
was also reviewed by the investigator with the NICU nurse educators on both day and 
night shifts to improve the adequacy of resources available to staff for compliance with 
study protocols.  
As required by nursing administration, a binder of study protocols and a “Nursing 
Standards of Care” document (Appendix B), was placed in the NICU in an area dedicated 
to the keeping of resource manuals.  Shortly after IRB approval, small group in-services 
were conducted for the bedside nurses, in the NICU patient pods, to assure awareness of 




addition, following IRB approval, the investigator used notices on the NICU bulletin 
boards to ascertain study awareness and remind staff of study resources and reference 
materials.  The investigator personally assured individual nurse knowledge regarding the 
study protocols and resources for those who were responsible to draw study labs during 
their shift by meeting with these individuals at the beginning of the nursing shift. 
Prior to pursuing IRB approval at Stony Brook Hospital, the study was presented to both 
the department chair of Pediatrics, the chief of Neonatology, the neonatal attending 
physician staff, and the appropriate division head of Nursing.   Following acceptance by 
these key personnel, the study was also formally presented to the medical and nurse 
practitioner staff of the NICU.   
The procedures developed in this study ensured fidelity of the implementation as well as 
assurance in the ethical conduct of the project.  This study was conducted in a setting 
where the investigator has served in the clinical role of a neonatal nurse practitioner.  In 
this role, she had been regularly involved in study recruitment, consent procedures, 
coordination of labs, and the collection of research data.  This experience strengthened 
the prospect of these processes progressing smoothly for the research.  For example, the 
investigator’s prior acquaintance with staff eased the process of coordinating the timing 
of research labs with routine clinical labs, and her familiarity with the clinical recording 
system enhanced the accuracy of data collected from the medical records.  Additionally, 
an existent mutual respect between nursing staff and the investigator augmented subject 
identification and adherence to the research protocols by the nursing staff.  Because of 




confusion by staff that the labs ordered for this study were for clinical purposes.  This 
distinction was emphasized by the investigator with the individual nurses who were 
responsible for drawing the labs at the beginning of the nursing shift.  Establishment of a 
separate medical record research encounter assured accuracy in billing and reporting of 
these labs even where misunderstanding may have existed. 
Measures 
This study employed the following measures to assess the major variables of interest, 
which were (a) random cortisol values in the 37
th
 postmenstrual week of age, (b) random 
17-OHP values in the 37
th
 postmenstrual week of age, (c) recurrent exposure to pain-
associated procedures and (d) hours of assisted ventilation.   
Quantitative chemiluminescent immunoassay was used to measure random cortisol 
in the 37th postmenstrual week of age (Advia Centaur, Siemens Inc., Cortisol test kit, 
analytical sensitivity 0.2 ug/dl).  A random cortisol value was defined as the level of 
cortisol in serum from a single resting blood draw, conducted by nursing staff, during the 
37th postmenstrual week of age.  For this study, cortisol values were described as 
“random,” rather than as “basal,” to reflect the free running rhythm (versus diurnal 
variation) that has been shown to be the hallmark of cortisol secretion in neonate 
(Economou, et al., 1993; Price, et al., 1983; Vermes, et al., 1980).   
Even in the absence of clear circadian patterns in young infants, the pulsatility feature of 
hormone secretion needed to be considered, whereby cortisol is secreted in 15 to 30 
shorts bursts throughout the day (Metzger, et al., 1993).  Low birthweight infants, 




time.  Therefore, a single random serum cortisol measurement has been proposed to be 
adequate in reflecting the adrenal status of these infants (Jett, et al., 1997). 
Test specimens were not batched, but instead analyzed as they became available, 
typically on separate days at ARUP Laboratories.  This is an appropriate method of 
laboratory collection and analysis for translational research, in that it emulates standard 
clinical procedures and standard laboratory analysis methods.  
Immunoassay is a method of testing biological liquids for the presence of an analyte (in 
this case, cortisol) using the analyte’s unique ability to bind to a specific group of 
molecules (usually an antibody or antigen).  In chemiluminescent immunoassay, a 
chemiluminescent dye is used that allows for the detection and quantification of cortisol 
binding events. Serum cortisol values were reported in micrograms per deciliter units. 
Quantitative radioimmunoassay was used to measure random 17-OHP in the 37th 
postmenstrual week of age (Wallac Wizard Gamma Counter, Siemens Inc., Coat-A-
Count 17A-OH progesterone test kit, analytical sensitivity 7 ng/dl).  A random17-OHP 
value was defined as the level of 17-OHP in serum from a single resting blood draw, 
conducted by nursing staff, during the 37
th
 postmenstrual week of age. 
Radioimmunoassay is a relatively inexpensive analytic technique in which a known 
concentrations of an antigen (in this case, 17-OHP) is radiolabeled and mixed with a 
known amount of antibody for that antigen.  After the two substances bind to one 
another, a sample of serum from a patient with an unknown quantity of antigen is added, 




measured, and the amount of antigen in the patient’s serum can be derived.  Serum 17-
OHP values were reported in nanograms per deciliter units. 
As was the case with cortisol specimens, 17-OHP specimens were not batched, and 
instead analyzed as they became available.   This emulated standard clinical and 
laboratory analysis procedures, such as is used for generating 17-OHP values from 
infants for the purpose of newborn state screening. 
A simple count of the total number of painful procedures sustained by each subject 
from birth up until the time of the serum cortisol measurement in the 37th 
postmenstrual week of age was used to measure recurrent exposure to pain-
associated procedures.  The number of painful procedures, as reported in the medical 
record from birth up until the time of serum cortisol measurement in the 37
th
 
postmenstrual week of age, was counted by the investigator to obtain this measurement.   
Procedures that had been categorized in previous research by Cignacco as “very painful” 
when carried out in the NICU were used  in this count of events (Cignacco, Hamers, et 
al., 2009).  These procedures include: endotracheal intubation, heel lance, arterial 
puncture, venipuncture (for any purpose), bladder puncture, lumbar puncture, thoracic 
needle or tube placement, suture placement, and subcutaneous or intramuscular injection.   
Porter’s study of procedural painfulness, as well as similar studies examining pain 
exposure in the NICU, supported that a count of intubations and/or skin-breaking 
procedures provides a reasonable measure of recurrent pain (Dodds, 2003; Porter, et al., 
1997; Rohrmeister, et al., 2003).  Furthermore, Grunau has suggested that a count of 




population, and that counting the total number of skin-breaking procedures from birth 
provides a marker of overall stress exposure (Grunau, et al., 2004).  
A simple count of the number of hours, up until the time of serum cortisol 
measurement in the 37th postmenstrual week of age, in which a subject received 
assisted ventilation, was used to measure hours of assisted ventilation.   The number 
of hours in which there was any application of assisted ventilation, as reported in the 
medical record, was counted by the investigator to obtain this measurement.   An infant 
was considered to be receiving assisted ventilation if requiring high-frequency ventilation 
(HFV), intermittent mandatory ventilation (IMV), or continuous positive airway pressure 
(CPAP), including the use of high flow nasal cannula (> 1 liter/minute flow ). 
In the NICU, assisted ventilation implies the need for endotracheal intubation or 
placement of CPAP/cannula prongs, recurrent device adjustment and securing to the face, 
regular placement and removal of adhesive oxygen saturation and/or transcutaneous 
carbon dioxide monitors, frequent repositioning of devices to avoid pressure-related skin 
breakdown, and repeated endotracheal and/or nasopharyngeal aspiration (Bonner & 
Mainous, 2008; Haney & Allingham, 1992).  Many of these procedures have been 
identified by Cignacco as a painful (Cignacco, et al., 2008).  
Various measures reflecting exposure to assisted ventilation have been described in infant 
adrenocorticoid studies.  Investigators have categorized infants as having required or not 
required assisted ventilation, or have operationalized this variable as a count of days from 
birth with mechanical ventilation or with supplemental oxygen.  Multicollinearity of this 




proven to be limitation in several studies  (Grunau, et al., 2007; Grunau, et al., 2005; 
Grunau, et al., 2010; Grunau, et al., 2004; Yamada, et al., 2007).  The correlation 
between days of mechanical ventilation and procedural pain exposure is plausible - sicker 
patients, such as those requiring assisted ventilation, typically need more diagnostic 
assessments and therapeutic interventions.  By collecting the number of total hours of 
assisted ventilation, rather than the number of days, the measurement of this variable is 
more precise.   
In addition to the measures used to assess the major variables in this study, other 
measurements were collected by the investigator to answer the research question: 
A simple count of the total number of painful procedures sustained by each subject 
in the 24 hours prior the time of serum cortisol measurement in the 37th 
postmenstrual week of age was used to measure recent exposure to pain-associated 
procedures.  The same procedures used in the measurement of recurrent exposure to 
pain-associated procedures were used in the measurement of this variable, but limited to a 
24 hour interval.  A count of painful procedures, as reported in the medical record for the 
24 hour period prior to cortisol measurement, was conducted.    
Identification of any occurrence of blood pH (including cord blood pH) less than 7.1, 
or any event of cardiopulmonary resuscitation requiring chest compressions was 
used to measure history of severe academia.  Measurement of this dichotomous 
variable was carried out using review of the medical record.    
Identification of any exposure to corticosteroids that had been administered 




measure exposure to antenatal steroids. Measurement of this dichotomous variable 
was carried out using review of the medical record.    
The measurement of gestational age was conducted for each infant by the obstetric 
staff using last menstrual period or prenatal ultrasound (where prenatal care had 
been obtained) or by the neonatal staff using the Ballard Score (where prenatal care 
had not been obtained).  The use of different methods of measurement to determine 
gestational age is common because of varied circumstances surrounding pregnancy and 
delivery.  These different methods have been found to produce reasonably comparable 
measurements (Ananth, 2007; Ballard et al., 1991).  The investigator collected the 
gestational age measurement from the NICU admission note.  Gestational age was 
recorded in fully completed weeks of gestation. 
The measurement of birthweight was conducted for each infant by nursing staff 
using a bedscale upon admission to the NICU.  The investigator collected this 
measurement from the NICU admission note.  Birthweight was recorded in grams.  
Identification of the day of age in which the infant had laboratory testing for cortisol 
and 17-OHP measurement was used to measure days of age at 37 postmenstrual 
weeks of age.  The investigator collected this measurement from the medical record and 





Identification of the interval number of days between the birth day and the day in 
which the infant had a subsequent weight at or above the birth weight was used to 
measure days of age to attain birthweight.  Days of age to attain birthweight was used 
as a measure of extrauterine growth velocity.  The investigator collected this 
measurement from the medical record and recorded the measurement in completed days 
of age, where the birth date was day of age #1. 
The measurement of weight at the 37th postmenstrual week of age was conducted 
for each infant by nursing staff using a bedscale.  Infant weight was used in the daily 
calculation of medications, calorie intake and output in the NICU.  Daily weight 
measurement was therefore a clinical preference, although some clinical situations 
required that an estimated weight be used.  Weight at the 37th postmenstrual week of age 
was defined as the last recorded measured weight prior to cortisol measurement in the 
37th postmenstrual week of age.  The investigator collected this measurement from the 
medical record.  Weight at the 37th postmenstrual week of age was recorded in grams.  
The assignment (measurement) of sex was conducted for each infant by visual 
inspection of the infant by staff members that were in attendance at the infant’s 
delivery.  The investigator collected this categorical measurement from the delivery 
room record, which was part of the medical record. 
Summary of Variables  





Table 3.2   
Summary of Study Variables 
Variable Data type Measurement units 
(categories) 
Random cortisol value Continuous  micrograms per deciliter 
Random 17-OHP value Continuous nanograms per deciliter 
Recurrent exposure to pain-associated 
procedures 
Continuous number of events 
Hours of assisted ventilation Continuous number of hours 
Recent exposure to pain-associated 
procedures  
Continuous number of events 
History of severe acidemia Categorical  (yes/no) 
Exposure to antenatal steroids Categorical  (any/none) 
Gestational age at birth Continuous completed weeks 
Birthweight Continuous grams 
Day of age Continuous  number of days 
Days of age to attain birthweight Continuous number of days 
Weight at the 37
th
 postmenstrual week of 
age 
Continuous grams 










Data Management and Analysis Plan 
Data analysis.  Data analysis proceeded in a stepwise fashion, moving from descriptive 
examination to inferential procedures as indicated and supported by the data.  Since the 
sample size was small, emphasis was placed on univariate and bivariate analyses.  
Limited multivariable analyses were planned as a final step to explore the data where 
such analyses could be supported.  Statistical tests included correlational analyses, tests 
of group differences, and simple linear regression. 
Data management.  The IBM SPSS Statistics 19 program was used for all data analysis 
procedures.  Prior to analysis, data management included a plan for the identification of 
missing values.  Because infants were not eligible for study recruitment if there was a gap 
in medical record data, missing values were expected to primarily relate to the 
measurements of cortisol and 17-OHP.  If only one of these two measurements was 
obtained, the infant was to remain in the study and analyses proceed for where there was 
complete data.  If neither cortisol nor 17-OHP measurements were able to be obtained in 
the 37
th
 postmenstrual week of age, then the infant data would not have been included in 
the analysis.  There was not to be imputation of missing data. 
The first phase of data analysis was descriptive.  Means, standard deviations and ranges 
were reported for continuous data (recurrent exposure to pain-associated procedures, 
hours of assisted ventilation, cortisol values, 17-OHP values, gestational age at birth, day 
of age, days of age to attain birthweight, birthweight, weight at the 37
th
 postmenstrual 
week of age and recent exposure to pain-associated procedures).  Relative frequencies 




severe acidemia).  As appropriate, continuous variables were categorized and relative 
frequencies reported.  For example, the measurement of recurrent exposure to pain-
associated procedures was presented in quartiles.  Visual inspection of distributions on 
continuous variables was conducted to assess for normality. 
Scatterplots were constructed for general inspection of the variables.  This included 
scatterplots for the examination of relationships between independent and dependent 
variables, as well as relationships among independent and dependent variables.  
Scatterplot inspection was followed by construction of a correlation matrix of all 
variables to identify statistically significant relationships.  This matrix was developed 
using Pearson or Spearman rank correlation in the case of continuous data, point-biserial 
correlation in the case of mixed data, and phi correlation in the case of dichotomous data.   
The major independent variables (recurrent exposure to pain-associated procedures, hours 
of assisted ventilation, gestational age at birth, sex, history of severe acidemia, and recent 
exposure to pain-associated procedures) were then examined for intercorrelations.  In the 
case of high intercorrelations ( >0.7), an opportunity existed to either collapse across 
highly correlated variables by deriving a secondary score or to drop less clinically 
significant variables from the predictive phase of the analysis, where necessary.   
Bivariate analyses (t-testing, paired sample t-testing, and non-parametric Mann Whitney 
U testing) was applied to examine differences in cortisol and 17-OHP values with respect 
to categories of age, sex, history of severe acidemia, and exposure to antenatal steroids.  
Grunau, Holsti and colleagues have examined differences in cortisol values in infants at 




The use of similar cutoffs for age was considered, in addition to considering the use of 
any naturally occurring cutoffs that presented in the data.   
The next phase of data analysis addressed the research hypotheses.  The first study 
hypothesis to be tested was as follows:  
Recurrent exposure to pain-associated procedures and hours of assisted ventilation will 
be negatively correlated with random cortisol values at 37 postmenstrual weeks of age. 
Correlational analysis was proposed to test this research hypothesis.  Because a 
directional hypothesis was established, one-tailed statistical tests were to be employed. 
Separate Pearson correlations between each of the two independent variables (recurrent 
exposure to pain-associated procedures and hours of assisted ventilation) and the 
dependent variable (random cortisol values) were planned to examine this relationship. If 
data was not normally distributed based upon visual inspection of distributions, then non-
parametric Spearman rank correlation was to be applied.  
The second study hypothesis to be tested was as follows:  
Recurrent exposure to pain-associated procedures and hours of assisted ventilation will 
be negatively correlated with random 17-OHP values at 37 postmenstrual weeks of age. 
Correlational analysis was proposed to test this research hypothesis.  Separate Pearson 
correlations between each of the two independent variables (recurrent exposure to pain-
associated procedures and hours of assisted ventilation) and the dependent variable 
(random17-OHP values) were planned, again using one-tailed statistical tests to reflect 




inspection of distributions, then non-parametric Spearman rank correlation was to be 
applied.  
After testing these research hypotheses, exploratory analyses would be conducted based 
upon their support by the data.  For example, multiple regression analyses or stepwise 
multiple regression analyses would be considered to evaluate the change of variance in 
cortisol or 17-OHP values at 37 postmenstrual weeks of age that is explained by recurrent 
exposure to pain-associated procedures and hours of assisted ventilation after controlling 
for other factors (gestational age, sex, history of severe acidemia and recent exposure to 
pain-associated procedures).   
Power analysis.   Power analysis was based upon the potential use of regression analysis. 
The power of the regression analysis was calculated using a sample size of 60 subjects, 
alpha set at 0.05, and two-tailed significance testing.  With two predictor variables 
(recurrent exposure to pain-associated procedures and hours of assisted ventilation) added 
to a set of up to four control variables (e.g.: gestational age at birth, sex, history of severe 
acidemia and recent exposure to pain-associated procedures), there is power of 0.75 to 
detect a moderate (f
2
 = 0.15) effect size for the outcome variable (random cortisol values 
or random17-OHP values) in each of the regression analyses.  
Protection of Human Subjects 
This research was conducted only after Institutional Review Board (IRB) protocol review 
and approval at Columbia University, where the study originated, and at Stony Brook 




Informed consent.  Informed consent was obtained in accordance with IRB guidelines 
for investigator review of medical records and for the collection of an additional aliquot 
of infant blood at 37 postmenstrual weeks of age during routine blood sampling.  An 
IRB-approved consent form was used (Appendix E).  The IRB required the consent of 
only one parent for this study based upon minimal risk in this research.  Consistent with 
local practice, which has been developed in the context of New York State paternity law 
and the federal Health Insurance Portability and Accountability Act (HIPAA) privacy 
rules, paternal consent could be obtained by the investigator only if the condition of 
marriage to the infant’s birth mother was met, or if there was documentation of paternity.  
A parent who consented to have his/her infant participate in the study was given a copy 
of the consent form.  No incentive to participate was offered.  Consenting parents were 
informed of their right to withdraw their infant from the study at any time prior to 
laboratory sampling.   In concordance with IRB policies of Columbia University and 
Stony Brook University, appropriate consent translation and/or the use of interpretation 
services were provided in cases where English is not the primary language of the parent.  
The population of parents of subjects in this study was expected to include a number of 
those who were not fluent in English, but who were fluent in Spanish.  The long form 
consent document was translated into Spanish.  Consistent with Stony Brook Hospital 
policy, Pacific Interpreters Inc. (www.pacificinterpreters.com) provided Spanish 
translation and interpretation services in the NICU.  For parents who were not fluent in 
English or Spanish, but who were fluent in another language or who were illiterate, 
appropriate interpretation services would have been similarly provided, and the short 




Confidentiality.  To maintain confidentiality, data files were maintained in a locked file 
and on a password-protected laptop computer that was maintained and safeguarded by the 
investigator and not accessible for unauthorized review.   Access to research files was 
limited to the investigators and the IRB.  Infant identifiers were used only for research 
purposes and will never be used in publication or presentation.  
In addition to providing standards for how identifiable health data is collected, stored and 
utilized in the course of research, the HIPPA impacts how protected health information 
can be used preparatory to research.  In concordance with these standards, any 
information recorded during the process of identifying infants who were eligible for 
inclusion in this study was deidentified.  Alphanumeric coding was used to protect the 




CHAPTER 4: Results 
This chapter presents the data analysis in detail.  Presentation begins with a description of 
the sample, as well as the results of analyses used to examine the stress variables and the 
glucocorticoid variables.  Bivariate correlation analyses of the major variables are next 
presented.  This is followed by a summary of the results of the statistical analyses used to 
test the research hypotheses.  The chapter concludes with the results of several 
exploratory analyses.  
Description of Sample 
Recruitment and inclusion. Sixty subjects were recruited from a pool of 94 infants 
admitted to the NICU at less than 35 completed weeks of gestation between May 1, 2012 
and September 12, 2012.  From the pool of 94 infants, 30 (31.9%) infants were ineligible 
to participate.  The reasons for ineligibility were IUGR (n=5, 5.3%), postnatal steroid use 
(n=1, 1.1%), transfer or surgery (n=4, 4.3%), early discharge (n=16, 17.0%) and death 
(n=4, 4.3%).  
Closer examination was made of the infants who were excluded because of death, 
transfer, surgery and postnatal steroid administration (n=9).   This group was comprised 
primarily of male infants (77.8%, 7/9).  All infants in this group had a birthweight under 
1000 grams (mean 791, range 640-960). 
A parent was able to be reached for consent for all eligible infant subjects.  Consent was 




disagreement regarding participation between the mother and the father.  The final rate of 
consent was 93.8% among the eligible subjects.   
Data from one subject was excluded because of late identification of IUGR.  This 
resulted in a final sample of 59 subjects.   
Laboratory testing was completed on all consented subjects.  There were no laboratory or 
sampling errors resulting in incomplete data collection.  All enrolled subjects had 
complete medical records, allowing for collection of all planned charted data.  















Figure 4.1.   





Characteristics of study sample.   Subjects had a mean gestational age of approximately 
31 weeks at birth and a mean birthweight of 1743 grams.  Males and females were 
similarly represented (47.5% female, 52.5% male).  The average length of time in the 
NICU prior to laboratory testing (equivalent to total days of age) was approximately 31 
days, and mean weight at the time of testing was 2342 grams.  A vast majority (94.9%) of 
subjects had been exposed to at least one dose of antenatal steroid, while only a minority 
(6.8%) had sustained severe acidosis. These results are summarized in Table 4.1.   
Self-reported race and ethnicity data was collected from each infant’s mother.  Bi-racial 
and bi-ethnic infants were noted to be common in this NICU, however paternal data was 
not collected.  The sample’s mothers self-defined as African-Americans in 13.6% of 
cases, as Caucasian non-Hispanics in 62.7% of cases, and as Caucasian Hispanics in 














Table 4.1   
Demographic Characteristics of Study Sample (n=59) 
Variable                                     Mean              Median              n           % 
                                   (+/-SD)             (range)  
Gestational Age in completed weeks                     30.8       31  
   (+ 2.24)            (25-34) 
 
Birthweight in grams           1743      1690  
      (+ 513)         (640-2880) 
 
37-Week Weight in grams           2342                 2305  
      (+ 372)         (1566-3170) 
 
Day of Age at Lab Testing           31.3                     27  
      (+ 16.4)            (14-69) 
 
Days of Age at to Attain Birthweight          11.9                     12  
       (+ 3.7)               (4-20) 
 
Recent Number of Procedural Exposures          0.39                    0  
           (+ 0.965)            (0-5) 
 
Sex 
 Male                  31  52.5 
 Female                  28  47.5 
 
Antenatal Steroids Exposure 
 Any         56  94.9 
 None           3  5.1 
 
History of Severe Acidemia  
 Any           4  6.8 
 None         55  93.2 
 
Mother’s Reported Race/Ethnicity 
African-American      8  13.6   
        Asian         0  0 
         Caucasian, Hispanic      14  23.7 
         Caucasian, non-Hispanic       37  62.7 






The sample had more representation of infants born at older gestational ages.  Only two 
infants in the sample were born at 25-26 completed weeks of gestation, but 19 infants 
were born at 33-34 completed weeks of gestation.  Twinning affected 25.5% (12/47) of 
the pregnancies represented by the data such that 39% (23/59) of the subjects in the study 
were a twin.  There was one subject who was not enrolled with her twin because of IUGR 
in the sibling.   Twins were also overrepresented among infants born between 29 and 30 
completed weeks of gestation, contributing to higher enrollment in this category (Table 
4.2).    
 
Table 4.2 
Breakdown of Subjects by Gestational Age and Distribution of Twins 
                              
Completed Weeks of 
Gestation at Birth 
    n                   %                twin 
                                          subjects                      
 
25-26           2             3.4            0 
 
27-28         5  8.5            2 
 
29-30       19           32.2           10 
 
31-32      14                 23.7            4  
 
33-34      19                 32.2            7 
_______________________________________________________ 
 








Distributions of demographic/potentially confounding variables.  The distributions of 
the independent variables of gestational age, birthweight, days of age to attain 
birthweight, number of recent pain-associated procedures, weight at testing and day of 
age at testing were examined for normality.  These distributions are described in Table 
4.3 and illustrated in Figures 4.2 through 4.7.   
The distribution of birthweight and days of age to attain birthweight both approached the 
normal distribution upon visual inspection.  The distributions for gestational age at birth 
and days of age at testing were expectedly imaged in opposite directions – fewer infants 
born at lower gestational ages corresponded with fewer chronologically older infants at 
the 37
th
 postmenstrual week of age.  In addition, while birthweight was relatively 
normally distributed (skew = 0.15), there was a mild shift to the left in infant weight at 37 
post menstrual weeks of age (skew=0.50) suggesting a differential in weight gain over 











Distribution Descriptors for Independent Variables  
                       Variable                                           Skewness              Kurtosis 
Gestational Age in completed weeks    -0.48      -0.46    
 
Birthweight in grams                                                        0.15                      -0.26 
 
Days of Age to Attain Birthweight                                 -0.14                      -0.26 
 




 Postmenstrual Week in grams                  0.50                      -0.30 
 











Distribution of Birthweight 
 
Figure 4.4 






Distribution of Recent Pain-Associated Procedures 
 
Figure 4.6 
Distribution of Weight at 37
th






Distribution of Days of Age at Lab Testing 
 
Addressing gestational age as a potential confounder.  An important potentially 
confounding variable in this study was gestational age.  The distribution for gestational 
age approached normal with a clustering at the upper gestational age range, consistent 
with the tendency for infants to be born closer to term (Figure 4.2).  Both the mean and 
median gestational age at birth in the study sample was approximately 31 weeks. 
In addition to its examination as a continuous variable, gestational age was recoded as a 
dichotomous variable to create comparison groups of infants born at a higher and lower 
gestational ages.   
The sample was divided in two ways for bivariate analyses.  First, the sample was 




under 31 completed weeks of gestation (“earlier-born,” n=26, 44.1%), and a group of 
infants born at the higher gestational age of at or over 31 completed weeks of gestation 
(“later-born,” n=33, 55.9%).   
Next, the sample was divided where a natural break in the data appeared, between 28 and 
29 completed weeks of gestation.  This created a group of infants born at the younger 
gestational age of under 29 completed weeks of gestation (“extremely premature,” n=7, 
11.9%), and a group of infants born at the higher gestational age of at or over 29 
completed weeks of gestation (“moderately premature,” n=52, 88.1%).   
Inter-rater Reliability Testing 
The following section presents analyses related to the key stressor variables.  Because 
counts of the key stressor variables were based only upon retrospective medical record 
review by the researcher, their accuracy was assessed through inter-rater reliability 
testing.  Inter-rater reliability provides a score of how much conformity there is between 
different raters.  Ten percent of the medical records were selected to be independently 
reviewed by an experienced neonatal nurse practitioner who was not otherwise involved 
in this investigation.  This reviewer was trained on the systematic process used for chart 
review by the investigator using a chart from the first subject in the study who had 
elements of assisted ventilation.  Each chart review was conducted to obtain a count of 
the number of hours that a subject received assisted ventilation (hours of assisted 
ventilation) and a count of the number of painful procedures sustained by each subject 
(recurrent exposure to pain-associated procedures) up until the time of serum cortisol 
measurement in the 37
th




examined comprised the clinical flowsheets and the results flowsheets.  In addition, for 
each chart, a review of the immunization history and procedural time-out sheets was 
conducted.   
Following training completion, the charts of the first two subjects completing laboratory 
analysis each week, for three consecutive weeks, were selected for inter-rater reliability 
testing.  At the end of the three week period, six charts (representing ten percent of the 
target number of subjects) were reviewed.   
Inter-rater reliability was assessed in two ways.  First, consistency between raters was 
assessed by calculating the Pearson correlations between raters for each of the data sets. 
For the count of number of hours that a subject received assisted ventilation, the overall 
Pearson correlation between raters was 0.999.  For the count of number of painful 
procedures, the overall Pearson correlation between raters was 0.966.     
Cohen’s Kappa can also be used in inter-rater reliability analysis to quantify the level of 
agreement between raters.  This statistic improves upon the Pearson correlation by taking 
into account the amount of agreement that could be expected to occur by chance between 
two raters.  The Kappa statistic indicates the proportion of agreement beyond that 
expected by chance, and can thereby verify that agreement between two raters exceeds 
chance levels.  For the count of painful procedures, the proportion of agreement between 
raters (the likelihood that the second reviewer agreed with the investigator about each 
exposure) was 0.775.  For the count of hours that a subject received assisted ventilation, 




statistically significant (p<0.001).  Landis and Koch have proposed that a Kappa statistic 
of 0.61-0.80 indicates substantial agreement between raters (Landis & Koch, 1977). 
Stressor Variables 
The first aim of this study was to characterize the nature of recurrent pain-associated 
procedures for infants in the NICU from birth up until the 37
th
 postmenstrual week of 
age.  Univariate and bivariate analyses were applied to provide a comprehensive 
characterization of this stressor variable, as well as characterization of exposure to 
assisted ventilation in this sample of infants.   
Recurrent exposure to pain-associated procedures.   A total of 3354 pain-associated 
procedures were identified for the 59 subjects (Table 4.4).  Premature infants were 
exposed to an average of 56.8 of procedures by their 37
th
 postmenstrual week of age.   
Heel lance, followed by venipuncture, was the predominant procedure to which infants 
were recurrently exposed.  Heel lance accounted for 80.8% of all procedures, while 
venipuncture accounted for 9.7% of all procedures.   
Over half of the procedures (56.5%) were carried out during the first week of age, and 
nearly one-third of the procedures (32.6%) occurred in the first three days of age (Table 
4.5).  Heel lance accounted for nearly two-thirds (65%, 717/1094) of procedures in the 
first three days of age, and three-quarters (74.4%, 1409/1895) of procedures in the first 








Characteristics of Recurrent Pain-Associated Procedures  
Recurrent 
Stressor 
Frequency (%)       Mean (+/- SD)       Median (range)   
  (n=3354)                  (n=59)                     (n=59) 
                                      
 
Tracheal Intubation      49 (14.6)           0.8 + 1.2          0 (0-5)    
 
Heel Lance  2710 (80.8)         45.9 + 37.7          33 (15-204) 
 
Arterial Puncture    103 (3.1)           1.8 + 2.1          1 (0-14) 
 
Venipuncture    324 (9.7)           5.5 + 3.9          5 (1-18) 
 
Lumbar Puncture        2 (0.06)         0.03 + 0.3          0 (0-2) 
 
Thoracic Puncture       7 (0.2)           0.1 + 0.7          0 (0-5) 
 
Suture Placement *     68 (2.0)           1.1 + 1.3          1 (0-7) 
 
IM/SQ Injection      91 (2.7)           1.5 + 0.9          1 (1-4) 
 
Bladder Puncture         0 (0)               0 + 0           0 (0) 
__________________________________________________________________________ 
 
Total                                  3354 (100)                   56.8 + 43.4                      42 (20-238)                       
______________________________________________________________ 













Recurrent Stressor Exposure in First Week of Age (n=59) 
 
Stressor    First 3-Day        First 3-Day          First Week        First Week 
   Freq (% of             Mean                Freq  (% of            Mean          
like procedure)         (range)             like procedure)        (range)               
                                 
Tracheal Intubation 32 (65.3) 0.5 (0-2)  41 (83.7) 0.7 (0-4) 
 
Heel Lance  717 (26.5) 12.2 (0-25) 1409 (52.0) 23.9 (10-44) 
 
Arterial Puncture  71 (68.9) 1.2 (0-3)  74 (71.8) 1.3 (0-3) 
 
Venipuncture  156 (48.1) 2.6 (0-12) 250 (77.2) 4.2 (0-17) 
 
Lumbar Puncture  0 (0)  0 (0)  0 (0)  0 (0) 
 
Thoracic Puncture 0 (0)  0 (0)  0 (0)  0 (0) 
 
Suture Placement  59 (86.8) 1 (0-3)  62 (91.2) 1.1 (0-3) 
 
IM/SQ Injection  59 (64.8) 1 (1-1)  59 (64.8) 1 (1-1) 
 
Bladder Puncture  0 (0)  0 (0)  0 (0)  0 (0) 
____________________________________________________________________________ 
 
Total                                  1094                      18.5                     1895                     32.1 
                                           (32.6)                    (8-33)                  (56.5)                   (16-55) 
____________________________________________________________________________ 
 
Hours of assisted ventilation.   A total of 17,328 hours of assisted ventilation were 
identified (Table 4.6).  Premature infants were exposed to an average of 293 hours of 
assisted ventilation up until their 37
th
 postmenstrual week of age of which 16.6% were in 
the form of invasive ventilation.   As expected, there was high exposure (31.8% of all 
hours) to assisted ventilation during the first week of age.  In addition, half of the hours 






Characteristics of Hours of Assisted Ventilation Exposure  
 Hours (%)        Mean (+/- SD)        Median (range)                                
(n=17328)             (n=59)                         (n=59) 
                                      
 
All Assisted  17328 (100)    293.2 + 397.2     142 (0-1583) 
Ventilation   
 
Invasive                        2883 (16.6)     48.9 + 145.5   0 (0-962) 
Ventilation 
 






Assisted Ventilation Exposure in First Week of Age (n=59) 
 
    First 3-Day        First 3-Day        First Week      First Week 
   Total                  Mean                  Total                Mean  
   (% of total)         (range)                (% of total)       (range) 
 
Hours of                2376                   40.3                     5517           93.5            
Assisted    (13.7)                 (0-69)                  (31.8)                (0-165) 
Ventilation   
(n=17328)                                                   
 
Hours of                              841                     14.3                     1444                24.5 
Invasive                               (29.2)                 (0-69)                  (50.1)               (0-165) 
Ventilation  
(n=2883)                                                    
  
Hours of                              1535                   26.0                     4073                69.0 
Non-invasive                       (10.6)                 (0-68)                   (28.2)             (0-158) 
Ventilation 







Distributions of stress variables.   The distributions of exposures to pain-associated 
procedures and hours of assisted ventilation were non-normal upon visual inspection 
(Figures 4.8 to 4.11).  All distributions were right-tailed, meaning that the highest 
numbers of exposures were limited to only few numbers of infants.  Skew and kurtosis 
measurements identified non-normality to be most marked for total hours of invasive 
ventilation (most infants were not exposed to invasive ventilation), and least marked for 
total hours of non-invasive ventilation (many infants received some exposure to non-
invasive ventilation) (Table 4.8).   
 
Figure 4.8 
























Distribution Descriptors for Stressor Variables  
                       Variable                                           Skewness              Kurtosis 
Number of Pain-Associated Procedures     2.5      6.8   
 
Total Hours of Assisted Ventilation               1.7      2.3 
 
Total Hours of Invasive Ventilation                          5.1     29.0 
 







Bivariate analyses.   Bivariate analysis using Mann Whitney U testing was used to 
examine if there were any significant differences in levels of recurrent exposure to pain-
associated procedures or hours of assisted ventilation based upon the demographic 
variable of gestational age (dichotomized in two ways) or sex.  Exposure to antenatal 
steroids was not examined as a in this type of bivariate analysis because nearly all 
subjects (94.9%, n=56) had this exposure.  Similarly, severe acidemia was not examined 
in this type of analysis because very few subjects (6.8%, n=4) had this exposure.   
Parametric and non-parametric testing was considered in light of the sample distributions 
and sample size.  Mann Whitney U testing was applied for these bivariate analyses 
because the distributions of the stressor variables were considered to be non-normal.  It 
was decided that parametric testing was to be applied where the skew of the distribution 
was <1, and nonparametric testing was to be applied where the skew of the distribution 
was >1.   
When comparing exposure to recurrent stressors by gestational age, the U value was 
significant (p < 0.001) indicating that there was a statistically significant difference in 
procedural exposure between the earlier-born and later-born infants, and between 
extremely premature and moderately premature infants, with a greater number of 
exposures among infants born at the lower gestational ages (Table 4.9).  For sex, the U 
value was not significant (p =0.298) indicating that there was not a statistically significant 
difference in procedural exposure between the male and female infants.  
When comparing exposure to assisted ventilation by gestational age, the U value was 




assisted ventilation exposure between the earlier-born and later-born infants, and between 
extremely premature and moderately premature infants (Table 4.10).  Again, as 
anticipated, there was a significantly higher exposure to ventilation for infants born at the 
lower gestational ages.  There was not a statistically significant difference in ventilation 
exposure between the male and female infants. 
 
Table 4.9 
Bivariate Analyses Testing for Differences in Recurrent Procedural Exposure 
 Variable          n              mean        U-statistic       P-Value* 
                          rank                                 
 
 
Gestational Age  
    Earlier-born                           26                42.6            110.0                   0.000† 
    Later-born                              33                20.1     
 
Gestational Age  
    Extremely Premature               7                50.2             40.5                    0.000† 
    Moderately Premature            52                27.3     
 
Sex 
    Male                                        31                27.8                  365.5                   0.298 
    Female                        28                32.45 
_____________________________________________________________ 
*Bivariate analyses were performed using Mann Whitney U test for independent samples 











Bivariate Analyses Testing for Differences in Assisted Ventilation Exposure 
Variable          n              mean        U-statistic       P-Value* 
                          rank                                 
 
 
Gestational Age  
    Earlier-born                           26                43.4            82           0.000† 
    Later-born                              33                19.5     
 
Gestational Age  
    Extremely Premature               7                54.1            13.0                     0.000† 
    Moderately Premature            52                26.8     
 
Sex 
    Male                                        31                29.3            412.5                   0.743 
    Female                        28                30.8 
_____________________________________________________________ 
*Bivariate analyses were performed using Mann Whitney U test for independent samples 
† Results significant at the 0.01 level  
 
Glucocorticoid Variables 
As previously described, quantitative chemiluminescent immunoassay was used to 
measure random cortisol values in the 37th postmenstrual week of age, and 
radioimmunoassay was used to measure random17-OHP values in the 37th postmenstrual 
week of age.   Cortisol was reported in micrograms per deciliter units and 17-OHP was 
reported in nanograms per deciliter units.   
Characteristics of cortisol and 17-OHP.   There was great variability in cortisol and 17-
OHP values for the premature infants at 37 postmenstrual weeks.  Random cortisol values 
ranged from 1.3 to 31.4 while random 17-OHP values ranged from 56 to 650 (Table 








Characteristics of Cortisol and 17-OHP Values at 37 Postmenstrual Weeks of Age 
(n=59) 
 
           Parameter                               Cortisol                  17-OHP  
                      (ug/dl)                    (ng/dl)                  
 
Range           1.3-31.4       56-650              
Mean           7.0             238                       
Median          4.4             215                      




 Quartile          2.6            157                      
3
rd




 Percentile          1.8            110                      
90
th
 Percentile          15.5             411                   
___________________________________________________________ 
 
As previously described, other researchers have examined cortisol and 17-OHP values at 
37 postmenstrual weeks of age for infants born at the lowest gestational ages (Al Saedi, 
Dean, Dent, & Cronin, 1995; Arnold, et al., 1997).   To compare our findings with these 
study results, data from subgroups of earlier-born infants in our study has been extracted 
and analyzed.  The characteristics of cortisol and 17-OHP at 37 postmenstrual weeks of 
age for infants born at under 30 weeks of gestation and at under 31 weeks of gestation are 














Characteristics of Cortisol and 17-OHP: Gestational Age Subgroups 
______________________________________________________________ 
                                    <31 Weeks Gestation         <30 Weeks Gestation 
Parameter Cortisol     17-OHP           Cortisol     17-OHP  
 (ug/dl)       (ng/dl)              (ug/dl)         (ng/dl) 
  n=26          n=26                  n=18           n=18     
 
Range              1.4-24.6       57-650           1.4-15.6     57-495 
Mean   6.6               250                   5.2              215 
Median  4.6               231                   3.9              179 




 Quartile  2.4         143                   2.0              129 
3
rd




 Percentile  1.8         77          1.8               57 
90
th




The distribution of cortisol values was non-normal upon visual inspection (Figure 4.12) 
while the distribution of 17-OHP values more closely approached the normal distribution 




Distribution Descriptors for Cortisol and 17-OHP Values 
                       Variable                                           Skewness              Kurtosis 
                        Cortisol          1.9      4.4        
 

















Bivariate analyses.   Bivariate analysis using Mann Whitney U testing was used to 
examine if there were any significant differences in values of cortisol or 17-OHP based 
upon the demographic variables of gestational age or sex.  Nonparametric testing was 
applied, again using the criteria that both sampling distributions were non-normal (skew 
>1).   
There were no significant difference in either cortisol or 17-OHP values with respect to 




Bivariate Analyses Testing for Differences in Cortisol Values 
Variable          n              mean        U-statistic       P-Value* 
                          rank                                 
 
 
Gestational Age  
    Earlier-born                           26                29.7            420           0.891 
    Later-born                              33                30.3     
 
Gestational Age  
    Extremely Premature               7                35.4            144.0                   0.387 
    Moderately Premature            52                29.3     
 
Sex 
    Male                                        31                29.1            405                      0.2660 
    Female                        28                31.0 
_____________________________________________________________ 








Bivariate Analyses Testing for Differences in 17-OHP Values 
Variable          n              mean        U-statistic       P-Value* 
                          rank                                 
 
 
Gestational Age  
    Earlier-born                           26                30.3            422.5                   0.0921 
    Later-born                              33                29.8    
 
Gestational Age  
    Extremely Premature               7                24.9            146.0                   0.413 
    Moderately Premature            52                30.7     
 
Sex 
    Male                                        31                30.8                  409.0                   0.704 
    Female                        28                 29.1 
_____________________________________________________________ 







Scatterplots.   Scatterplots were developed to inspect for patterns of linearity among the 
major variables of interest.   
First, scatterplots were developed to examine for linear relationships between the two 
major stressor variables (recurrent exposure to pain-associated procedures and hours of 
assisted ventilation) and to examine for linear relationships between two adrenocorticoid 
variables (random cortisol values and random 17-OHP values) (Figures 4.14 and 4.15).  
Inspection of these scatterplots suggests that there is a strong positive linear relationship 
between the two major stressor variables and a weak positive linear relationship between 




Figure 4.14  
Scatterplot: Recurrent Pain-Associated Procedures versus Hours of Assisted Ventilation  
 
 
Figure 4.15  






Next, scatterplots were developed to examine for linear relationships between the two 
major stressor variables and cortisol (Figures 4.16 and 4.17).  Inspection of these 
scatterplots suggests that there is not a linear relationship between either of the major 
stressor variables and cortisol. 
 
Figure 4.16  
Scatterplot: Recurrent Pain-Associated Procedures versus Cortisol 









Figure 4.17  
Scatterplot: Hours of Assisted Ventilation versus Cortisol 
 
       
Finally, scatterplots were developed to examine for linear relationships between the two 
major stressor variables and 17-OHP (Figures 4.18 and 4.19).  Inspection of these 
scatterplots suggests that there may be a weak negative linear relationship between 
recurrent pain-associated procedures and 17-OHP, but no relationship between hours of 








Figure 4.18  
Scatterplot: Recurrent Pain-Associated Procedures versus 17-OHP 
   
 
Figure 4.19  
Scatterplot: Hours of Assisted Ventilation versus 17-OHP 




Correlation matrices.   Correlation matrices were constructed using all of the variables 
to explore these relationships and examine for confounding.  The first matrix was 
developed using phi correlation for the cases of dichotomous data (Figure 4.20).  The 
second matrix was developed using point-biserial correlation for the cases of mixed data 
(Figure 4.21).  The third matrix was developed using Spearman rank correlation, for the 
cases of continuous data where there was a skew >1 in the distribution of at least one 
variable (cortisol, 17-OHP, recurrent pain-associated procedures, all ventilation variables, 
recent pain-associated procedures) (Figure 4.22).  The final matrix was developed using 
Pearson correlation in the cases of continuous data with more normal distributions 
(Figure 4.23). 
As expected, severe acidemia was significantly negatively correlated (p<0.01) with 
earlier gestational age (r= -0.493), lower birthweight (r= -0.440), age at testing (r=           
-0.489), greater procedural pain exposure (r= -0.695), and greater exposure to ventilation 
(r= -0.559).  Additionally, male sex was found to be significantly correlated (p<0.05) 
with higher birthweight (r= -0.292), higher weight at testing (r= -0.383) and lower 











Figure 4.20  
Phi Correlation Matrix 
 
Sex 







Sex Phi Correlation 1 .284* .220 
Sig. (2-tailed)  .029 .094 
N 59 59 59 
History of Severe Acidemia 
(any/none) 
Phi Correlation  1 .062 
Sig. (2-tailed)   .639 
N  59 59 
Antenatal Steroid Exposure 
(any/none) 
Phi Correlation   1 
Sig. (2-tailed)    
N   59 














Figure 4.21  








Cortisol Value(ug/dl) Point-Biserial Correlation .071 .013 .107 
Sig. (2-tailed) .593 .921 .421 
N 59 59 59 
17-OHP Value (ng/dl) Point-Biserial Correlation -.148 -.218 -.079 
Sig. (2-tailed) .264 .097 .550 
N 59 59 59 
Number of Pain-Associated 
Procedures  
Point-Biserial Correlation .094 .695** .236 
Sig. (2-tailed) .478 .000 .072 
N 59 59 59 
Total Hours of Assisted 
Ventilation  
Point-Biserial Correlation .135 .559** .058 
Sig. (2-tailed) .309 .000 .663 
N 59 59 59 
Total Hours of Invasive 
Assisted Ventilation 
Point-Biserial Correlation .074 .705** .210 
Sig. (2-tailed) .577 .000 .110 
N 59 59 59 
Total Hours of Non-invasive 
Assisted Ventilation 
Point-Biserial Correlation .140 .319* -.051 
Sig. (2-tailed) .290 .014 .704 
N 59 59 59 
Gestational Age at Birth 
(completed weeks) 
Point-Biserial Correlation -.193 -.493** -.195 
Sig. (2-tailed) .143 .000 .138 
N 59 59 59 
Birthweight (grams) Point-Biserial Correlation -.005 -.440** -.292* 
Sig. (2-tailed) .972 .000 .025 
N 59 59 59 
Days of Age to Attain 
Birthweight 
Point-Biserial Correlation .137 .082 .053 
Sig. (2-tailed) .301 .535 .690 
N 59 59 59 
Weight at Testing (grams) Point-Biserial Correlation .149 -.305* -.383** 
Sig. (2-tailed) .261 .019 .003 
N 59 59 59 
Day of Age at Testing Point-Biserial Correlation .133 .489** .124 
Sig. (2-tailed) .317 .000 .348 
N 59 59 59 
Number of Recent Pain-
Associated Procedures  
(prior 24 hours) 
Point-Biserial Correlation .094 .242 .180 
Sig. (2-tailed) .478 .064 .172 
N 59 59 59 
* Correlation is significant at the 0.05 level (2-tailed). 








Figure 4.22  
























  Cortisol Value (ug/dl) Spearman Coefficient 1.000      
Sig. (2-tailed) .      
N 59      
17-OHP Value (ng/dl) Spearman Coefficient .247 1.000     
Sig. (2-tailed) .059 .     
N 59 59     
Number of Pain-
Associated Procedures  
Spearman Coefficient -.044 -.232 1.000    
Sig. (2-tailed) .742 .077 .    
N 59 59 59    
Total Hours of Assisted 
Ventilation 
Spearman Coefficient -.047 -.132 .824** 1.000   
Sig. (2-tailed) .723 .318 .000 .   
N 59 59 59 59   
Total Hours of Invasive 
Assisted Ventilation 
Spearman Coefficient -.070 -.071 .685** .819** 1.000  
Sig. (2-tailed) .598 .592 .000 .000 .  
N 59 59 59 59 59  
Total Hours of Non-
Invasive Assisted 
Ventilation 
Spearman Coefficient -.041 -.127 .820** .991** .792** 1.000 
Sig. (2-tailed) .760 .336 .000 .000 .000 . 


















































  Cortisol Value (ug/dl) Spearman Coefficient .071 .088 .083 .042 -.008 .156 
Sig. (2-tailed) .591 .507 .531 .750 .953 .238 
N 59 59 59 59 59 59 
17-OHP Value (ng/dl) Spearman Coefficient .045 .064 .028 -.080 -.140 -.148 
Sig. (2-tailed) .738 .631 .831 .547 .290 .265 
N 59 59 59 59 59 59 
Number of Pain-
Associated Procedures ( 
Spearman Coefficient -.753** -.672** .407** -.182 .801** .443** 
Sig. (2-tailed) .000 .000 .001 .167 .000 .000 
N 59 59 59 59 59 59 
Total Hours of Assisted 
Ventilation 
Spearman Coefficient -.762** -.598** .512** -.031 .777** .279* 
Sig. (2-tailed) .000 .000 .000 .816 .000 .032 
N 59 59 59 59 59 59 
Total Hours of Invasive 
Assisted Ventilation 
Spearman Coefficient -.721** -.632** .334** -.095 .728** .236 
Sig. (2-tailed) .000 .000 .010 .472 .000 .072 
N 59 59 59 59 59 59 
Total Hours of Non-
Invasive Assisted 
Ventilation 
Spearman Coefficient -.753** -.599** .551** -.019 .771** .256 
Sig. (2-tailed) .000 .000 .000 .886 .000 .051 
N 59 59 59 59 59 59 
Gestational Age at  
Birth  
(completed weeks) 
Spearman Coefficient 1.000     -.223 
Sig. (2-tailed) . P P P P .089 
N 59     59 
Birthweight (grams) Spearman Coefficient  1.000    -.243 
Sig. (2-tailed)  . P P P .064 
N  59    59 
Day of Age When 
Attains Birthweight 
Spearman Coefficient   1.000   .279* 
Sig. (2-tailed)   . P P .032 
N   59   59 
Weight at Testing 
(grams) 
Spearman Coefficient    1.000  -.251 
Sig. (2-tailed)    . P .055 
N    59  59 
Day of Age at Testing Spearman Coefficient     1.000 .281* 
Sig. (2-tailed)     . .031 
N     59 59 
Number of Recent Pain-
Associated Procedures 
(prior 24 hours) 
Spearman Coefficient      1.000 
Sig. (2-tailed)      . 
N      59 
* Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). 

















Day of Age 
When Attains 
Birthweight 
Day of Age at 
Testing 
Weight at Testing 
(grams) 
Gestational Age at  
Birth  
(completed weeks) 
Pearson Correlation 1 .858** -.262* -.936** .211 
Sig. (2-tailed)  .000 .045 .000 .109 
N 59 59 59 59 59 
Birthweight (grams) Pearson Correlation  1 -.139 -.796** .566** 
Sig. (2-tailed)   .295 .000 .000 
N  59 59 59 59 
Day of Age When  
Attains Birthweight 
Pearson Correlation   1 .293* -.037 
Sig. (2-tailed)    .025 .783 
N   59 59 59 
Day of Age at Testing Pearson Correlation    1 -.054 
Sig. (2-tailed)     .684 
N    59 59 
Weight at Testing  
(grams) 
Pearson Correlation     1 
Sig. (2-tailed)      
N     59 
*Correlation is significant at the 0.05 level (2-tailed). 




Identification of collinearity.   Collinearity among the study variables can impede 
statistical analyses and required identification prior to the exploratory regression 
analyses.  For this research, collinearity was defined as a highly significant correlation of 
> 0.7 or < -0.7 (p<0.001).  Multicollinearity existed between the two major stressor 
variables (r= 0.824), as well as between each of the major stressor variable and several of 
the other study variables (Table 4.16).  Collinearity also existed between hours of 
invasive and non-invasive ventilation (r=0.792), and gestational age at birth was collinear 
with birthweight (r=0.858), day of age at testing (r= -0.936), and total hours of non-
invasive (r= -0.753), and invasive ventilation (r= -0.721).  Of note, birthweight was not 






Identification of Collinearity 
 Variables             Recurrent                    Hours of                                 
Pain-Associated               Assisted  
            Procedures                 Ventilation 
                          (r)                                (r) 
 
Gestational Age                                            -0.753    -0.762 
Days of Age at Testing                              0.801     0.777 
Birthweight                             (n/a)     (n/a) 
 
Hours of Invasive Ventilation               (n/a)     0.819 
Hours of Non-invasive Ventilation               0.820     0.991 
_____________________________________________________________ 
Collinearity is defined as a highly significant correlation of > 0.7 or < -0.7  
All results are significant at < 0.001 level  
 
The lack of collinearity between recurrent pain-associated procedures and hours of 
invasive ventilation warranted further exploration.  It was anticipated that infants 
requiring the greatest ventilatory support would have had the highest incidence of 
procedural pain exposure.  The early placement of central arterial and venous catheters in 
our sample of infants requiring assisted ventilation was postulated as the factor that 
precluded collinearity between procedural pain exposure and hours of invasive 
ventilation.  To test this hypothesis, Spearman rank correlation (1-tailed) was conducted 
to examine the relationship between invasive ventilation in the first week of age and 
suture placement in the first week of age.  A single suture was used in this NICU during 
three procedures - umbilical arterial catheter placement, umbilical venous catheter 
placement, and thoracic tube placement.  As no thoracic tubes were placed in this sample 
of infants during the first week of age, all sutures during this time were related to a 




1444 hours of invasive ventilation (50.1% of all hours) and 62 suture placements (91.2% 
of all sutures).  The correlation between these variables was 0.783 (p<0.001), indicating a 
significant positive relationship between hours of invasive ventilation and suture 
placement (or, in this case, a significant positive relationship between hours of invasive 
ventilation and umbilical line placement).   
Hypothesis Testing  
The second aim of this study was to examine relationships between recurrent exposure to 
pain-associated procedures, hours of assisted ventilation, and random cortisol and 17-
OHP values at 37 postmenstrual weeks of age in a sample of premature infants who had 
received care for a minimum of two weeks in the NICU. 
Correlation between stressor exposure and cortisol values.   The first hypothesis 
associated with this study aim was:  
Recurrent exposure to pain-associated procedures and hours of assisted ventilation will 
be negatively correlated with random cortisol values at 37 postmenstrual weeks of age. 
Correlation analysis was proposed to test this research hypothesis.  Spearman rank 
correlation was applied (one-tailed) because the distributions of cortisol, recurrent pain-
associated procedures and hours of assisted ventilation were determined to be non-normal 
based upon visual inspection and examination of skew (skew >1).    
There was not a significant linear relationship between recurrent exposure to pain-
associated procedures and random cortisol values at 37 postmenstrual weeks of age.  In 




ventilation and random cortisol values at 37 postmenstrual weeks of age. The first 
research hypothesis was not supported (Table 4.17). 
 
Table 4.17 
Hypothesis Testing: Correlations between Stressor Variables and Cortisol 
_____________________________________________________________ 
                Cortisol  
_____________________________________________________________ 
 
Stressor Variable                                      n=59                        P-value*     
_____________________________________________________________     
 
Number of Pain-Associated                    -0.044    0.371 
Procedures  
 
Total Hours of Assisted                          -0.047     0.362 
Ventilation  
_____________________________________________________________ 
* Analyses were performed using one-tailed Spearman rank correlation 
 
 
Correlations between cortisol values and the ventilation subgroups (hours of invasive and 
non-invasive ventilation) were additionally analyzed but failed to reveal significant 










Correlations between Ventilation Variables and Cortisol 
_____________________________________________________________ 
             Cortisol 
_____________________________________________________________ 
 
Ventilation Variable                                n=59                        P-value*     
_____________________________________________________________     
 
Hours of Invasive                                    -0.70                         0.299 
Assisted Ventilation 
 
Hours of Non-invasive 
Assisted Ventilation                                -0.041     0.380 
_____________________________________________________________ 
* Analyses were performed using one-tailed Spearman rank correlation 
 
 
Correlation between stressor exposure and 17-OHP values.   The second hypothesis 
associated with this study aim was: 
Recurrent exposure to pain-associated procedures and hours of assisted ventilation will 
be negatively correlated with random 17-OHP values at 37 postmenstrual weeks of age. 
Correlation analysis was proposed to test this research hypothesis.  Spearman rank 
correlation was applied (one-tailed) because the distributions of 17-OHP, recurrent pain-
associated procedures and hours of assisted ventilation were determined to be non-normal 
based upon visual inspection and examination of skew (skew >1).    
There was a significant negative correlation between recurrent exposure to pain-
associated procedures and random17-OHP values at 37 postmenstrual weeks. There was 
not a significant relationship between hours of assisted ventilation and random17-OHP 





Hypothesis Testing: Correlations between Stressor Variables and 17-OHP 
_____________________________________________________________ 
             17-OHP  
_____________________________________________________________ 
 
Stressor Variable                                      n=59                        P-value*     
_____________________________________________________________     
 
Number of Pain-Associated                    -0.232    0.039† 
Procedures  
 
Total Hours of Assisted                          -0.132     0.159 
Ventilation  
_____________________________________________________________ 
* Analyses were performed using one-tailed Spearman rank correlation 
† Correlation is significant at the 0.05 level  
 
 
Correlations between 17-OHP and the ventilations subgroups were additionally analyzed 
but failed to reveal significant findings (Table 4.20).   
 
Table 4.20 
Correlations between Ventilation Variables and 17-OHP     
_____________________________________________________________ 
            17-OHP  
_____________________________________________________________ 
 
Ventilation Variable                                 n=59                        P-value*     
_____________________________________________________________     
 
Hours of Invasive                                    -0.071                        0.296 
Assisted Ventilation 
 
Hours of Non-invasive 
Assisted Ventilation                                -0.127     0.168 
____________________________________________________________ 





Since there was not a correlation between 17-OHP and hours of assisted ventilation, 
regression analysis for this aspect of the second research hypothesis could not be 
supported. 
A regression model for 17-OHP, however, was developed using the predictor variable of 
recurrent exposure to pain-associated procedures.  Correlation analyses were reviewed 
for other significant predictor variables to include in this analysis, and the use of 
birthweight was considered.  Birthweight was significantly correlated with recurrent 
exposure to pain-associated procedures (r= -0.672) however did not meet the definition 
for collinearity.  
A simple linear regression was created of recurrent pain-associated procedures on 17-
OHP values.  In this univariable model, the coefficient for recurrent pain-associated 
procedures was -0.502 indicating that for each additional procedural exposure, there was 
a decrease in the 17-OHP value by 0.5 ng/dl (Table 4.21).  The R
2
 of this model indicates 
that only 1.7% of the variance in 17-OHP values can be explained by recurrent pain-










Summary of Simple Linear Regression Model for 17-OHP 
__________________________________________________________________________ 
 
 Independent Variable              Adj β             SE         t           Sig.       Adj. R2  
     
__________________________________________________________________________     
 
Recurrent Pain-                     -0.502          0.354 -1.421            0.161                
Associated Stress     
             0.017
    





A multiple linear regression model was next created of recurrent pain-associated 
procedures on 17-OHP values after controlling for birthweight.  The percent of variability 
accounted for in the prediction of 17-OHP increased from 1.8% to 2.7% with the addition 
of the stressor variable to a model already including birthweight (Table 4.22).  Neither 
the first model (birthweight) nor the second model (birthweight plus pain-associated 
procedures) predicted 17-OHP values to a statistically significant degree (p=0.984, 











Summary of Multiple Linear Regression Model for 17-OHP 
__________________________________________________________________________ 
 
 Independent Variable              Adj β           SE         t         p-value    Adj. R2    
__________________________________________________________________________     
 
Birthweight                            -0.001           0.030            -0.020           0.984            
 
 Model                                                                                                   0.984             -0.018  
__________________________________________________________________________ 
 
Birthweight      -0.050          0.039    -1.264         0.211 
 
Recurrent Pain-                     -0.887          0.465   -1.907         0.062                   
Associated Procedures     
 





Testing of collinear variables.   Because of collinearity between recurrent pain-
associated procedures and hours of assisted ventilation, hours of invasive ventilation, 
hours of non-invasive ventilation, gestational age, and day of age, these variables could 
not be used together in the regression analysis.  The extent to which these variables and 
birthweight were related to 17-OHP, in comparison the recurrent pain-associated 
procedures, was examined in another way.  Using a one-tailed model, the relationship 
between each of these variables and 17-OHP was examined for the strength of a 
directional (negative) correlation.  These analyses failed to identify any other significant 







Table 4.23   
Correlations between 17-OHP and Collinear Study Variables 
_____________________________________________________________ 
                 17-OHP  
_____________________________________________________________ 
Variable                                                n=59             P-value*     
_____________________________________________________________     
 
Recurrent Pain-Associated Procedures           -0.232 0.039† 
 
Days of Age       -0.140  0.145 
 
Hours of Assisted Ventilation          -0.132  0.159 
 
Hours of Non-invasive Ventilation   -0.127  0.168 
 
Hours of Invasive Ventilation                         -0.071  0.296 
 
Gestational Age     0.045  0.369 
_____________________________________________________________ 
* Analyses were performed using one-tailed Spearman rank correlation 




Recent pain-associated procedures.    Previous research by Holsti has described 
alterations in ACTH and cortisol values in premature infants at 32 postmenstrual weeks 
of age who had been exposed to skin-breaking procedures in the previous 24 hours  
(Holsti, et al., 2007).  Bivariate analysis using Mann Whitney U testing was conducted to 
examine for differences in cortisol values relative to recent procedures in this data set.  
The recent pain-associated procedure variable was recoded as a dichotomous variable 
(any/none) to create comparison groups of infants who had any procedural pain exposure 
in the previous 24 hours (13/59, 22%) and no procedural pain exposure in the previous 24 




There were no differences in either cortisol or 17-OHP values between infants who had 
and had not been exposed to any pain-associated procedures in the previous 24 hours 
(Table 4.24).  For this sample, it does not appear that adrenocorticoid values remain 




Bivariate Analyses Testing for Differences in Glucocorticoid Values after Recent Pain-
Associated Procedures  
 
 Variable N                mean                U-statistic               P-Value* 
                   rank                                                  
 
Cortisol 
    Any recent pain              13         35.4          229                     0.200 
    No recent pain                46         28.5     
 
17-OHP 
    Any recent pain              13                  24.7                       230                     0.207 
    No recent pain                46                  31.5 
___________________________________________________________________________ 
*Bivariate analyses were performed using Mann Whitney U test for independent samples 
 
   
Birthweight and weight gain.   As previously described, male sex was correlated with 
higher birthweight, as well as higher weight at 37 postmenstrual weeks of age.  Further 
analysis using independent samples t-testing revealed significant differences in weight 








Bivariate Analyses Testing for Differences in Weight between Male and Female Infants 
Variable              N            mean        t-statistic       P-Value* 
                             (SD)                              
 
Birthweight 
     Male                      31       1885 (487)      2.31             0.025†  
     Female            28       1587 (504)     
 
37-Week Weight 
    Male             31       2476 (371)     3.13             0.003††      
    Female               28       2193 (317)  
_____________________________________________________________ 
*Bivariate analyses were performed using independent samples t-testing 
† Results significant at the 0.05 level  
†† Results significant at the 0.01 level  
 
Correlation analysis also revealed significant relationships between days of age to attain 
birthweight and all of the stress variables (recurrent pain-associated procedures, hours of 
assisted ventilation, hours of invasive ventilation and hours of non-invasive ventilation).  
This data was further examined in two ways.  First, the two major stressor variables were 
divided at the median and the days of age to attain birthweight were examined for 
significant differences.  Next, days of age to attain birthweight was divided at the median 
and the two major stressor variables were examined for significant differences. 
Mann Whitney U-Testing revealed significant differences in both recurrent pain-
associated procedures and hours of assisted ventilation with respect to days of age to 
attain birthweight, as well as significant differences in days of age to attain birthweight 








Bivariate Analyses Exploring Days to Attain Birthweight and Exposure to Stressors 
 
                  Variable                          N              mean         U-statistic          P-Value* 
                                           rank                                    (95% CI) 
 
Recurrent Pain-Associated Procedures 
    Attain Birthweight < 12Days              35         24.4.            224               0.002† 
    Attain Birthweight > 12 Days               24         38.2  
 
Hours of Assisted Ventilation 
    Attain Birthweight < 12 Days              35         22.9            171                0.000† 
    Attain Birthweight > 12 Days          24         40.4     
 
Days of Age to Attain Birthweight 
    Recurrent Pain < 42 Events                   30                  24.2             262               0.008† 
    Recurrent Pain > 42 Events          29                  36.0 
 
Days of Age to Attain Birthweight 
    Assisted Ventilation < 142 Hours              30                  22.4              206              0 .000† 
    Assisted Ventilation > 142 Hours 29                  37.9 
___________________________________________________________________________ 
*Bivariate analyses were performed using Mann Whitney U test for independent samples 
†Results significant at the 0.01 level  
 
 
Extrauterine growth velocity is an important indicator of infant health, just as the rate of 
“catch-up” growth following early life disease has been used as a proxy for premature 
infant resilience.  Using independent sample t-testing (2-tailed) the data were examined 
to see if there were differences in adrenocorticoid values between infants who had earlier 
attainment of their birthweight and infants who had later attainment of their birthweight.   
There were no differences in cortisol or 17-OHP at 37 postmenstrual weeks of age 
between infants who had earlier attainment of their birthweight and infants who had later 






Bivariate Analyses Testing for Differences in Glucocorticoid Values between Infants who 
Attain Birthweight Earlier and Later 
Variable              N            mean        t-statistic       P-Value* 
                             (SD)                              
 
Cortisol 
     Early (< 12 days)                     24       6.7 (5.7) -0.207             0.837  
     Late  (> 12 days)            35       7.1 (6.3)     
 
17-OHP 
    Early (< 12 days)            24       222 (108) -0.822             0.415      
    Late  (> 12 days)             35       248 (125)  
_____________________________________________________________ 
*Bivariate analyses were performed using independent samples t-testing 
 
 
The 90th percentile of stress.   Grunau and colleagues suggested that there may be a 
critical threshold of stressful exposures that must be reached before seeing an adaptation 
of the HPA axis (Grunau, et al., 2005).   To examine this hypothesis, adrenocorticoid 
values in infants whose stressful exposures were above the 75
th
 percentile for this sample 
distribution were compared to infants whose stressful exposures were below the 25
th
 
percentile for this sample distribution. Non-parametric Mann Whitney U testing was 
applied after the appropriate sampling quartiles were identified.   
There were no significant differences in cortisol values between infants who had 
experienced the highest stressor exposure compared with those who had experienced the 
lowest stressor exposure for both recurrent pain-associated procedures and for hours of 
assisted ventilation (Table 4.28).   In addition, there was no significant difference in 17-




compared with those who had experienced the lowest stressor exposure for assisted 
ventilation. The difference in 17-OHP values between infants who had been exposed to 
the greatest number of recurrent pain-associated procedures compared with those who 
had been exposed to the lowest number of recurrent pain-associated procedures, however,  
approached significance (p=0.068) (Table 4.29).   
 
Table 4.28 
Bivariate Analyses Testing for Differences in Cortisol Values between Infants with 
Extremes of Stress Exposure 
 Variable              N            mean        U-statistic       P-Value* 
                            rank                                
 
Number of Pain-Associated Procedures 
    
    > 75
th
 % (> 67 procedures)          15       16.9          92  0.395 
    < 25
th 
% (< 31 procedures)           15       14.1    
 
Total Hours of Assisted Ventilation 
     
    > 75
th
 % (> 355 hours)                 15                15.2                        108               0.852 
    < 25
th
 % (< 10 hours)               15                15.8 
_____________________________________________________________ 











Bivariate Analyses Testing for Differences in 17-OHP Values between Infants with 
Extremes in Stressor Exposure 
Variable              N            mean        U-statistic       P-Value* 
                            rank                                 
 
Number of Pain-Associated Procedures 
    
    > 75
th
 % (> 67 procedures)          15       18.4         68.5              0.068 
    < 25
th 
% (< 31 procedures)           15       12.6     
 
Total Hours of Assisted Ventilation 
    
    > 75
th
 % (> 355 hours)                 15                16.4                        98.5              0.581  
    < 25
th
 % (< 10 hours)                15                14.6 
_____________________________________________________________ 
*Bivariate analyses were performed using Mann Whitney U test for independent samples 
 
 
Twins.   There were eleven sets of twins with complete data represented in the database.  
To this point in the analysis, the data from the infant subjects was considered to be 
independent.  The availability of twin data, however, presented a unique opportunity to 
examine differences in adrenocorticoid values with respect to birthweight.  While it is 
well-accepted that IUGR is associated with long-term alterations in cortisol, there may 
also be alterations in adrenocorticoid values for infants who are small at birth as a result 
of relative intrauterine stress, but who do not fit the strictest criteria for IUGR.    
Bivariate analysis using paired sample t-testing was conducted to examine for differences 
in cortisol and 17-OHP values between the larger-born and smaller-born of twins.  One 




There were no differences in either cortisol values or 17-OHP values between the larger-
born and smaller-born of twins although the results are cautionary given the small sample 
size (Table 4.30).   
 
Table 4.30 
Bivariate Analyses Testing for Differences in Glucocorticoid Values between Larger-
Born and Smaller-Born Twins 
 Variable N            mean              mean              t-statistic        P-Value* 
                 (SD)          difference                                 
                                        (SD) 
 
Cortisol 
    Larger-born                 10           4.5 (3.9)            -1.2 (6.8)         -0.554                0.593              
    Smaller-born                 10           5.7 (3.9)   
 
17-OHP 
    Larger-born                  10            235 (104)         2.8 (166)          0.053                 0.959 
    Smaller-born     10            233 (174) 
___________________________________________________________________________ 





CHAPTER 5: Discussion 
Introduction 
This study examined the relationship between cortisol and 17-OHP values at 37 
postmenstrual weeks of age and two major types of pain-associated stressor exposure in 
premature infants during hospitalization in the NICU.  This study is the first to describe 
both cortisol and 17-OHP values in relation to pain-associated procedural exposure and 
hours of assisted ventilation in a sample of premature infants who had received at least 
two weeks of NICU care. 
Of importance, this study establishes that there is a statistically significant relationship 
between recurrent pain-associated procedural exposure in premature infants and an aspect 
of their adrenocorticoid profile at 37 postmenstrual weeks of age.  This research 
supported the hypothesis that recurrent exposure to pain-associated procedures was 
negatively correlated with random 17-OHP values at 37 postmenstrual weeks of age (r=   
-0.232, p=0.039).  A trend was also identified for differences in 17-OHP values between 
infants who had the highest and lowest pain-associated procedural exposure (U=68.5, 
p=0.068).   
Dissociation between stress and cortisol values in early infancy has been identified across 
numerous previous studies (Holsti, et al., 2007; M. Lee, et al., 1989).  In concordance 
with these earlier results, this research also finds no significant relationship between 
recurrent pain-associated procedures (r= -0.044, p=0.742) or hours of assisted ventilation 
(r= -0.047, p=0.723) and cortisol values in premature infants at 37-postmenstrual weeks 




The findings of this research does not support that recurrent pain-associated procedural 
exposure is predictive of 17-OHP values at 37 postmenstrual weeks (adj R
2
= 0.017, 
p=0.161) and does not establish a relationship between length of assisted ventilation and 
17-OHP values at 37 postmenstrual weeks (r= -0.132, p=0.318).  While support of the 
correlational hypothesis gives reason to pursue this line of inquiry, inability to identify a 
predictor of hormonal values at 37 postmenstrual weeks of age emphasizes that there 
remains much to be learned about the factors that influence the adrenocorticoid profile of 
prematurely born infants.  
This study is also important in that it successfully tackled some of the difficult tasks 
associated with clinical translational research.  In particular, the study was not impeded 
by lack of affordable in-house laboratory testing, successfully utilizing an outside clinical 
laboratory for specimen analysis.  The separation of the clinical and research records was 
successfully accomplished through novel admitting department mechanisms.  In addition, 
coordination of research activities with clinical activities in this intensive care unit was 
found to be feasible, diminished patient burden, and was likely a factor that supported 
IRB approval.   Success in conducting the research in this patient-oriented way, rather 
than using bench science methodologies, has important implications for promoting the 
integration of research findings into practice.  Should future research support 17-OHP as 
a physiologic indicator for cumulative NICU stress, then support for its use as a practical 
biomarker is strengthened by knowledge of its feasible collection using routine clinical 





The following sections of this discussion will address specific findings of this study.  
This will include an examination of specific variables, relationships that were identified 
between variables, and the comparison of this study’s findings to those of other 
investigators.  Finally, strengths, challenges and limitations are discussed, as well as 
implications for practice and future research.   
Cortisol and 17-OHP Values 
Previous research has suggested that glucocorticoid values in both term and premature 
infants vary in relation to postmenstrual age (Bolt, Van Weissenbruch, et al., 2002b; 
Holsti, et al., 2007; Linder, et al., 1999).  While, normative data for random cortisol and 
17-OHP values are widely available for term infants at standardized postmenstrual ages 
(e.g.: at term birth), comparatively little data is available for premature infants in whom 
standardization for postmenstrual age is made difficult by varying gestational ages at 
birth.  Consequently, there is speculation regarding the clinical significance of cortisol 
and 17-OHP values in NICU practice, particularly cases of low serum cortisol and high 
serum 17-OHP values. 
Nevertheless, we compare the results obtained in this sample of infants to results obtained 
in similar samples by other researchers.  In 1995, Al Saedi and colleagues reported 
weekly cortisol and 17-OHP values for 39 infants born at under 31 weeks of gestation up 
until the 37
th
 postmenstrual week of age (Al Saedi, et al., 1995).   In 1997, Arnold and 
colleagues followed cortisol and 17-OHP values to 16 weeks of age in premature infants 
born at under 30 weeks of gestation (Arnold, et al., 1997).  Cortisol and 17-OHP values at 




These findings can be compared to cortisol and 17-OHP values from subgroups of infants 
in the current study (see Table 4.12).  To facilitate comparison, hormone values were 
standardized across studies and presented in micrograms per deciliter units.  
 
The median cortisol values in the current study sample were higher than the results 
reported by both Al Saedi and by Arnold (Table 5.1).  These values, however, are within 
the broad accepted range for infants in their first year of age (Soldin, Brugnara, & Wong, 
2003).  One explanation for this difference may relate to nutritional status differences of 
the premature infants in the studies, which were conducted approximately 15 years apart.  
In each of these studies, total cortisol was measured, rather than biologically active 
(unbound) free cortisol.  Values of nutrient transport proteins are recognized as an 
etiology for cortisol variance in hospitalized patients (Beishuizen, Thijs, & Vermes, 
2001; Langer, et al., 2006).  Improvements in parenteral and enteral nutrition for 
premature infants over the years have targeted circulating values of albumin transport 
proteins (van den Akker et al., 2007), which were not measured as part of the 
adrenocorticoid hormone studies.  Reported cortisol values in these studies do not 
accurately reflect the actual secretion and action of unbound cortisol and may be different 
across studies related to the hormone component that is bound to transport proteins.    
In 2010, Ballerini and colleagues examined 38 premature infants who were divided by 
gestational age at birth (Ballerini, et al., 2010). Among infants born at < 32 weeks of 
gestation (age range 7-90 days), a median cortisol value of 4.8 was reported (range 1.0-
13.8), and among infants born at > 32 weeks of gestation (age range 3-45 days), a median 








Characteristics of Cortisol (ug/dl) at 37 Postmenstrual Weeks of Age:  
Comparisons with Other Researchers 
____________________________________________________________________ 
                            <31 Weeks Gestation         <30 Weeks Gestation         0-24 months 
 
Parameter Rohan         Al Saedi           Rohan         Arnold           Soldin 
 n=26            n= 30                n=18            n=12   
 
Range   1.4-24.6        nr            1.4-15.6         nr            1.0-34 
Mean   6.6          nr                      5.2                 nr 
Median  4.6          2.8                    3.9                 1.2 




 Quartile  2.4          nr                      2.0                 1.0 
3
rd




 Percentile  1.8          1.1           1.8                 nr 
90
th
 Percentile  15.2          11.5                  9.7                 nr 
________________________________________________________________ 
nr: not reported 
Conversion factor for cortisol: ug/dl cortisol x 27.59 = nmol/l cortisol 
(Al Saedi, et al., 1995; Arnold, et al., 1997; Soldin, et al., 2003) 
 
 
The 17-OHP values in the current study sample were higher and with a greater spread 
than the results reported by Al Saedi, but lower than those reported by Arnold (Table 
5.2).  Small sample sizes and differences in the methods of serum analysis (Ballerini, et 






Characteristics of 17-OHP (ng/dl) at 37 Postmenstrual Weeks of Age:  
Comparisons with Other Researchers 
______________________________________________________________ 
                                    <31 Weeks Gestation         <30 Weeks Gestation 
 
Parameter   Rohan      Al Saedi            Rohan       Arnold  
   n=26          n=30                 n=18          n=11  
 
Range   57-650          nr           57-495          nr 
Mean   250               nr                     215               nr 
Median  231          170                  179               284 




 Quartile  143          nr                     129              238 
3
rd




 Percentile  77          97          57                 nr 
90
th
 Percentile  447          292                  430               nr 
___________________________________________________________ 
nr: not reported 
Conversion factor for 17-OHP: ng/dl 17-OHP x 33 = nmol/l 17-OHP 
(Al Saedi, et al., 1995; Arnold, et al., 1997) 
 
The findings from this study also support that cortisol values may be low in premature 
infants without signifying acute disease.  In the current study sample, 15/59 (25.4%) 
infants had cortisol values under 3 ug/dl, and 8/59 (13.6%) had values under 2 ug/dl.  
While acuity was not measured as a discrete variable, there were no infants in this study 
receiving invasive ventilation at 37 postmenstrual weeks and all were without 
intravenous devices at that time.  This suggests a lack of acute disease at the time of 




Recurrent Exposure to Pain-Associated Procedures  
The first aim of this study was to characterize the nature of recurrent pain-associated 
procedures for premature infants in the NICU from birth up until the 37
th
 postmenstrual 
week of age.  Relatively little research has examined the frequency of exposures to 
recurrent invasive procedures in premature infants during their NICU hospitalization.  
This study adds to a growing body of work that examines the infant experience of 
recurrent pain-associated exposures relative to NICU hospitalization. 
During this study, 59 infants were collectively exposed to 3354 pain-associated 
procedures, for an average of approximately 57 invasive procedures per infant (see Table 
4.4).  The greatest number of individual exposures was 238, and no infant was exposed to 
fewer than 20 procedures.  The overwhelming burden of these exposures was during the 
first few days of age.  Over 56% of exposures were in the first week after birth, and over 
32% of exposures were during the first 48-72 hours of age.   
The majority of the recurrent procedural exposures for this sample of premature infants 
were from heel lance and venipuncture (see Table 4.4).  Heel lances are often considered 
relatively benign procedures in the NICU, however collectively comprised over 80% of 
the pain-associated events.  The premature infants averaged exposure to approximately 
24 heel lances during the first week of age.  Venipunctures also comprised a substantial 
portion of the pain-associated exposures.  The conservative method of retrospective chart 
review identified over 15 venipuncture events in the first week of age for some of the 




Previous studies have reported exposure to pain-associated procedures for premature 
infants during the course of hospitalization.  Using retrospective chart review in which 
secondary attempts at primary procedures were routinely documented, Grunau and 
colleagues reported procedural exposure for three samples of infants.   In these studies, 
there was a mean exposure during NICU hospitalization of 193, 204 and 129 procedures 
for infants born at a gestational age of 22 to 28 weeks, and a mean exposure of 72, 61 and 
52 procedures for infants born at a gestational age of 29 to 32 weeks (Grunau, et al., 
2007; Grunau, et al., 2010; Grunau, et al., 2004).  
Grunau’s findings provide data for reasonable comparisons. Although the current study 
examines procedural exposures only up until 37 postmenstrual weeks of age, and 
Grunau’s study examines data from the entire NICU hospitalization, it appears that 
procedural exposure greatly diminishes with hospitalization and approaching discharge. It 
might be expected that there are relatively few procedures represented in Grunau’s data 
past the 37
th
 postmenstrual week of age.  In addition, it appears that many premature 
infants are discharged close to the 37
th
 postmenstrual week of age.  After removing 
infants who were born at over 32 weeks of gestation, comparisons were made between 
Grunau’s study findings and the current study findings.   
In the current study there was a mean total exposure to 138 procedures for infants born at 
a gestational age of 25 to 28 weeks (n=7), and a mean total exposure to 54 procedures for 
infants born at a gestational age of 29 to 32 weeks (n=33).  These values are comparable 
to the exposures identified by Grunau.  In the current study, however, counts of painful 




Carbajal, we know that secondary attempts at primary procedures considerably augment 
the overall number of exposures to painful procedures (Carbajal, et al., 2008).  It is 
therefore suspected that the actual exposure in the study institution greatly exceeded the 
exposures reported by Grunau, suggesting differences in invasive procedure use across 
institutions.  Presuming that the modern institutions in which these studies were 
conducted had similar infant outcomes, variability in practice implies that there may be 
different ways to achieve the similar outcome endpoints.  There may be an opportunity to 
adjust practices to reduce painful exposures for premature infants in the NICU without 
affecting standard infant outcomes.    
Recent Pain-Associated Procedures  
Holsti and colleagues identified a correlation between cortisol values and the number of 
recent skin-breaking procedures in premature infants at 32 postmenstrual weeks of age, 
as well as a difference in ACTH values in infants who had been exposed to higher versus 
lower numbers of recent painful stressors (Holsti, et al., 2007).  To follow up on these 
observations, the relationship between both cortisol and 17-OHP values and the number 
of recent exposures to pain-associated procedures was examined.  This study did not 
identify a significant correlation between the number of recent exposures to pain-
associated procedures and either cortisol (r=0.156; p=0.238) or 17-OHP (r= -0.148; 
p=0.265) values.  In addition, after recoding the recent pain-associated procedures 
variable to a dichotomous variable, the cortisol and 17-OHP values of infants who had 
been exposed to any pain-associated procedures in the previous 24 hours were compared 
to those of infants who had not been exposed to any such procedures (see Table 4.24).  




(p=0.207) between these groups of infants.  This research was unable to support Holsti’s 
proposition that pain exposure induces a proximate “down-regulation” of the HPA axis.  
Only a small number of infants in the current study sample, however, had been exposed 
to recent pain-associated procedures (n=13/59), limiting the generalizability of findings. 
Days of Age to Attain Birthweight 
The correlation between days of age to attain birthweight and each of the stress variables 
(recurrent pain-associated procedures, hours of assisted ventilation, hours of invasive 
ventilation and hours of non-invasive ventilation) was significant at the 0.01 level.  
Further longitudinal studies would be necessary to understand if premature infants grow 
slowly when they are exposed to numerous pain-associated procedures, or if altered 
metabolism and slow growth is part of the illness condition which predisposes premature 
infants to higher levels of intensive care.   
To this point, the association between extrauterine growth velocity and adrenocorticoid 
activity of premature infants has not been described.  In our research, there was not a 
significant correlation between days of age to attain birthweight and either cortisol values 
(r=0.083; p=0.531) or 17-OHP values (r=0.028; p=0.831).  There remains a lack of 
evidence to support a relationship between this marker of infant resilience and these 
aspects of the adrenocorticoid profile in premature infants. 
Male/Female Differences 
For the subjects in this study, male sex was significantly correlated with higher 
birthweight, higher weight at 37 postmenstrual weeks of age, and lower incidence of 




and 37-week weight between male and female infants, with males having a higher weight 
at both points.  These findings prompted further exploration, as premature male infants 
have been reported to have higher morbidity (Tyson, Parikh, Langer, Green, & Higgins, 
2008). 
Further analysis revealed that the exclusionary criteria of transfer/surgery, postnatal 
steroid exposure and death, predominantly disqualified extremely low birthweight, male 
infants (77.8%, 7/9) from study participation.  When the birthweights of the nine 
excluded infants are included in a bivariate analysis (n=68), there was no longer a 
statistically significant difference between males and females for birthweight (t=1.023, 
p=0.310).  Data was not available to conduct similar bivariate analyses using 37-week 
weight and incidence of acidosis.   While male infants included in the study have 
indicators of superior health when compared to the female infants (higher weight at birth, 
higher weight at 37 weeks, and lower incidence of severe acidosis), this must be 
considered in the larger context: Among the pool of infants who were cared for in the 
NICU for over two weeks, there was primarily exclusion of male infants with complex 
health issues.  
Previous research has both identified (Ballerini, et al., 2010; Grunau, et al., 2010) and 
failed to identify (Grunau, et al., 2007; Grunau, et al., 2005; Heckmann, et al., 2000; 
Scott & Watterberg, 1995) differences in cortisol and 17-OHP values between male and 
female infants.   In our sample we failed to identify differences in cortisol values 




of different exclusionary criteria among these studies, it continues to be difficult to 
interpret these results in a clinically meaningful way.    
Multicollinearity 
Collinearity between study variables impacted certain statistical analyses. Many of these 
relationships were predictable.  For example, there was multicollinearity between 
gestational age at birth, total hours of ventilation and procedural pain exposure.  More 
immature infants have a higher incidence of disease at birth necessitating treatment with 
assisted ventilation and more diagnostic testing.   Similarly, there was multicollinearity 
between gestational age at birth, birthweight and day of age at testing.  More immature 
infants have a lower birthweight and a longer interval of NICU care between birth and 37 
postmenstrual weeks of age.  Except for birthweight (which only approached collinearity 
with recurrent pain-associated procedures,  r= -0.672), this study’s findings of collinearity 
were similar to the findings of Grunau and colleagues, who identified multicollinearity 
between number of skin breaking procedures, birthweight, days of mechanical ventilation 
and gestational age (Grunau, et al., 2005; Grunau, et al., 2010; Grunau, et al., 2004; 
Grunau, et al., 2009).    
The relationship between procedural pain exposure and hours of invasive ventilation    
(r= 0.685) was noted for a lack of collinearity and explored.  Premature infants receiving 
assisted ventilation typically require more frequent laboratory monitoring, and are 
commonly restricted on enteral feedings, necessitating the maintenance of intravenous 
access.  For infants requiring the highest levels of respiratory assistance - invasive 




procedural pain exposure, total hours of ventilation and hours of non-invasive ventilation 
existed, the lack of collinearity between recurrent pain-associated procedures and hours 
of invasive ventilation was unexpected.  It was anticipated that invasive ventilation would 
be highly collinear with procedural pain exposure. 
A collinear relationship was instead identified between hours of invasive ventilation in 
the first week of age and suture placement in the first week of age (r=0.783; p<0.001).  
The majority of hours of invasive ventilation occurred during the first week of age in this 
sample (see Table 4.7).  In addition, all sutures placed in the first week of age were for 
the securement of central arterial and venous catheters (see Table 4.5).  These deep 
catheters were used for blood draws and fluid infusions, precluding the need for many 
heelsticks and venipunctures.  This significant relationship between suture placement and 
hours of invasive ventilation suggests that the use of central umbilical catheters during 
the first week of age in infants who require invasive ventilation serves to attenuate their 
exposure to recurrent pain-associated procedures. 
Relationship between Study Variables and Adrenocorticoid Values  
Hypothesis testing for this study did not identify a significant correlation between 
recurrent exposure to pain-associated procedures or between hours of assisted ventilation 
and cortisol values at 37 post-conceptual weeks of age.  Similarly, a significant 
correlation could not be identified between hours of assisted ventilation and 17-OHP 
values at 37 post-conceptual weeks of age.   
An important finding of this study was support of the hypothesis that recurrent exposure 




OHP values at 37 postmenstrual weeks of age (r= -0.232; p=0.039).  In addition, there 
was a trend for differences in 17-OHP values between infants with the highest and lowest 
recurrent pain-associated procedural exposure.   
Due to multicollinearity, it was not possible to examine the independent effects of 
recurrent pain-associated procedures, gestational age, hours of ventilation and days of age 
on 17-OHP values.  This was concerning, as gestational age (and birthweight) had been 
previously identified as important factors in the variability of 17-OHP values (J. Lee, et 
al., 2008a; Ryckman, et al., 2012).  The extent to which the collinear variables and 
birthweight were related to 17-OHP, relative to the relationship between recurrent pain-
associated procedures and 17-OHP, was instead examined using one-tailed correlation 
analyses.   These analyses identified the strength of the negative linear relationships 
between the infant variables and 17-OHP at 37 postmenstrual weeks of age, and provided 
an opportunity to compare these relationships to the strength of the significant negative 
correlation between recurrent pain-associated procedures and 17-OHP (Table 4.23).   
These exploratory analyses failed to identify any other significant linear relationships 
between the infant variables and 17-OHP.  The strength of the linear relationship (and the 
level of significance) between 17-OHP and each of the study variables diminished 
successively after recurrent pain-associated procedures as follows: days of age (r= -0.140; 
p=0.145), hours of assisted ventilation (r= -0.132; p=0.159), hours of non-invasive 
ventilation (r= -0.127; p=0.168), hours of invasive ventilation (r= -0.071; p=0.296), 
gestational age (r= 0.045; p=0.369), and birthweight (r= 0.064; p=0.631).  While limited 




birthweight and gestational age may not necessarily be more important than recurrent 
procedural exposure in explaining the variability of 17-OHP values.  Although further 
research using larger samples is needed, exposure to recurrent pain-associated procedures 
has the potential for being an even more specific indicator of 17-OHP values at 37 
postmenstrual weeks of age compared to other infant variables. 
The extent to which birthweight was related to 17-OHP values was also examined in an 
exploratory regression analysis (see Table 4.22).  In this multiple linear regression 
analysis of recurrent pain-associated procedures on 17-OHP values, the independent 
effect of birthweight on 17-OHP values was examined when it was used as a control 
variable in the model.  The percent of variability accounted for in the prediction of 17-
OHP by birthweight was 1.8% which was not statistically significant (t= -0.020, 
p=0.984).   
In 2004, Grunau examined the effect of neonatal factors on cortisol values at eight month 
of age and encountered a similar problem of collinearity between gestational age and 
procedural exposure (Grunau, et al., 2004).  After controlling for illness severity, and 
days of supplemental oxygen, she identified that a higher number of neonatal procedures 
independently predicted basal cortisol values at 8 months of age.  To evaluate whether 
gestational age rather than procedures was the operative factor, regression analysis was 
repeated with substitution of gestational age for procedural exposure.  This analysis did 
not identify a relationship between gestational age and basal cortisol at 8 months of age.  
Researchers concluded that procedural exposure appeared to be the key factor in 




It is important to consider that the relationship between the stressor variables and 17-
OHP may be quadratic, or otherwise nonlinear.  The scatterplots depicting the 
relationships between the stressor and outcome variables were examined in this regard.  
There were not any nonlinear relationships detected in this examination. 
Recruitment and Sampling Issues 
The overall consent rate for this study was 93.3%.  Taking twinning into account, where 
one parent was able to consent for two subjects, a total of 96% of parents who were 
approached agreed to study enrollment for their infants.  A prospective, multi-center 
PICU study examining surrogate consent rates for pediatric critical care research reported 
a consent rate of 79.4% for non-therapeutic studies (Menon et al., 2012).  Differences in 
consent processes, parental perceptions of illness and illness severity make it difficult to 
extrapolate findings to research in other settings.   
Our high rate of consent for this study may be related to a pre-established parental 
acceptance of blood sampling as part of the existing NICU routine, or a function of the 
high levels of trust that parents report for nurses (and in this case, a nurse-investigator).  
In addition, as previously described, this study was conducted in a setting where the 
investigator had served in a clinical role as a neonatal nurse practitioner.  This long, 
positive clinical relationship may have enhanced staff support of parents who were 
considering participation in the research investigation. 
The sampling methodologies and exclusion criteria used in this study resulted in an 
overrepresentation of infants born at higher gestational ages (see Table 4.2).  It was 




representation of infants with younger gestational ages through the mechanism of infant 
transport.  Instead of similar enrollment across gestational age categories, the gestational 
age distribution  is more reflective of the data from the National Vital Statistics Report in 
which there is a negative correlation between birth rate and gestational age (Martin, 
2011). 
Twins are reported to represent 3.3% of all live births nationally (Kochanek, Kirmeyer, 
Martin, Strobino, & Guyer, 2012), however are overrepresented among premature births.  
Twinning affected 25.5% (12/47) of the pregnancies represented by our data such that 
39.0% (23/59) of the subjects in our study were a twin (see Table 4.2).   
Study Strengths  
While the overall sample size was relatively small, the reported results represent one of 
the larger cohorts of infants examined for a relationship between stressor exposure and 
subsequent adrenocorticoid production, as well as one of the few NICU cohorts in which 
recurrent pain-associated stressor exposure has been quantified.   
As previously mentioned, this study also has value because of its translational - rather 
than bench science - approach.  Should future research support 17-OHP as a physiologic 
indicator for cumulative NICU stress, then support for its use as a practical biomarker is 
strengthened by knowledge of its feasible collection using routine clinical and laboratory 
procedures.  
This study also represents an initial attempt to validate the life cycle model of stress 
(Lupien, et al., 2009) for explaining the influence of stressful exposures on differentiation 




This model is important because it turns attention from the study of immediate biological 
and physiological responses to stress, which are relatively well described in infancy, and 
instead provides a framework for understanding the more lasting impact of stress 
adaptation.    
Challenges and Limitations 
Obtaining an accurate count of pain-associated procedures using a review of the medical 
record was limited by a deficiency of data describing supplemental attempts at primary 
skin-breaking procedures, likely reducing the count of recurrent pain-associated 
procedures to significantly less than the actual occurrence.  The need for supplemental 
attempts at primary procedures was recognized by Carabjal and colleagues’ using direct 
observation techniques (Carbajal, et al., 2008).  In their research, it was identified that 
over 35 percent of procedures performed in the NICU were supplemental attempts at a 
primary procedure, with some painful procedures needing as many 10 to 15 attempts for 
completion.  These supplemental attempts were not found to be typically recorded in the 
medical record.  Researchers have noted that these repeated attempts are therefore 
difficult to capture using chart review methods (Simons et al., 2003).   
At the time of this study, records were not routinely maintained in the NICU regarding 
secondary attempts at primary procedures, although this information was occasionally 
available in a nursing “free text” note.  The number of times that such documentation of 
secondary attempts at primary procedures occurred was in less than 0.5% of all 




audit likely under-represents the actual number of recurrent pain-associated procedural 
exposures. 
Medical record review is complicated by other documentation practices as well. All 
studies using medical record review are limited because of the potential for recording 
errors, and because records are only maintained for selected factors. The medical records 
reviewed for this study were primarily electronic. The study site converted to electronic 
charting in 2011, and training was still incomplete.  In addition, for the electronic records, 
there were ongoing documentation process changes being implemented by the hospital’s 
Computer Informatics Department throughout the course of the study.  These changes, 
while aimed at improving the quality of the nursing documentation, may have resulted in 
a higher incidence of charting errors as nurses transcended a learning curve.    
There are many methodological challenges in adrenal hormone research, particularly in 
studies of premature infants, in whom sampling can be difficult, and frequently yields 
inadequate amount of specimen.  While the use of standard clinical and laboratory 
procedures may have enhanced the translational value of this study, the use of these 
methods may have resulted in a loss of precision in laboratory values.  Similarly, while 
research has proposed that a single measurement of cortisol is adequate in reflecting the 
adrenal status of a premature infant, the results obtained in this study may have in some 
way been affected by the pulsatile nature of cortisol.   Caution needs to be exercised 
when drawing conclusions about adrenal axis function based upon the premise of single 




The results of the analyses also need to be considered in the context of overall stress 
exposure for premature infants who are cared for in the NICU. While recurrent skin-
breaking procedures and assisted ventilation comprise a considerable burden of stress for 
premature infants, there was not control for exposures to many other stressor variables.  
Light, noise and hypothermia have all been identified as stressors for this population 
(Bissinger & Annibale, 2010; Bremmer, Byers, & Kiehl, 2003; Perlman, 2001) and may 
contribute to the adrenocorticoid phenotype that evolves after NICU care.  Prenatal 
stressors have additionally been implicated to impact offspring, even by contributing to 
premature delivery (Hobel, Goldstein, & Barrett, 2008).  Cocaine exposure is an example 
of one such potentially HPA-axis altering prenatal exposure which was not examined in 
this study (Bauer et al., 2011; Scafidi et al., 1996).  Conversely, the buffering effects of 
maternal caregiving, kangaroo holding and careful attention to developmental 
interventions may have selectively modified the impact of stressors for certain infants. 
These variables were not measured.   
The study sample was one of convenience, and results may for that reason not be 
generalizable to other NICU infant populations.  For example, the regional transport 
center where this study was conducted is different from many other centers in that it 
covers a broad county with a sparse public transportation system.  Premature birth at this 
hospital leaves many parents with NICU visitation difficulties.  The center is also a state 
facility where a disproportionately high percentage of premature infant hospitalization 
costs are covered under the Medicaid system.  A scarcity of financial resources 
exacerbates transportation difficulties for many families.  It is plausible that differences 




infants who were enrolled in this study and the general population of premature infants 
who are cared for in the NICU may have impacted the study results.     
Finally, while a power analysis was conducted, it was based upon a moderate to large 
effect size for exploratory research.  This resulted in a relatively small sample size, and 
raises concern for Type II error.   
Implications for Practice 
The information gained by this research adds to our ability to quantitatively describe the 
cumulative exposure to stressors experienced by premature infants in the NICU.   In the 
course of this research, using counts of invasive procedures and hours of assisted 
ventilation, a more accurate representation of pain-associated stressor exposure has 
emerged.  This information can potentially be used to develop exposure benchmarks for 
neonatal intensive care.  As indicated, there may be differences in exposure rates between 
the study institution and other research centers.  Examination of variability in practices 
across institutions provides a potential opportunity to reduce pain-associated procedural 
exposure for premature infants without compromising other outcome benchmarks.   
Difficulty in obtaining an accurate count of pain-associated exposures points to an 
opportunity for improved documentation practices in the NICU.  Incorporating fields into 
the electronic medical records to capture primary and secondary attempts at skin-
breaking procedures for NICU patients may enhance quantification of this variable, and 
potentially improve upon our ability to identify the impact of these recurrent procedures.   
Direct-observation techniques continue to be the gold standard for collecting clinical data 




methods are expensive and often not feasible.  In addition to improving upon the methods 
of provider documentation, exploration of video or other newer electronic technologies 
for research purposes may improve reliability of such clinical measurements.    
This study provides evidence that the use of central umbilical catheters during the first 
week of age in infants who require invasive ventilation may serve to attenuate their 
exposure to recurrent pain-associated procedures.   The first week of age has been 
demonstrated to be a time when almost every premature infant in this study sustained the 
highest burden of recurrent pain-associated procedures.  The risks of umbilical catheter 
placement have traditionally been balanced by factors such as provider convenience and 
data accuracy.  The findings from this study suggest that, outside of the obligation to 
provide humane care, these catheters may serve to reduce an exposure which may have 
endocrinologic implications for premature infants.  Guidelines for the placement of these 
catheters warrant review in the context of this new information. 
Implications for Research 
The results from this study provide reason to pursue further examination of the 
relationship between cumulative stressor exposure in premature infants and adaptations 
of their adrenocorticoid profile.  There is a need to examine recurrent stressor exposure 
using measures affording greater accuracy, in larger samples of premature infants.  More 
research is needed in samples including younger and sicker infants – particularly male 
infants - and ones with high stressor exposure if we are to gain meaningful knowledge 




premature infants.  The use of longitudinal studies to examine variability in these values 
through the first year of age would also be important.    
As previously mentioned, using similar measures of procedural pain exposure, Grunau 
and colleagues identified a relationship between high procedural pain in premature 
infants who were cared for in the NICU and basal cortisol values at 8 and 18 months of 
age, as well as a relationship between high procedural pain exposure and diminished 
neuro-cognitive outcomes at 8 and 18 months of age.  A relationship between high 
procedural pain exposure and 17-OHP values at 37 postmenstrual weeks in this 
population has now been identified.  Research examining the relationship between 17-
OHP values at 37 postmenstrual weeks and neuro-cognitive outcomes at 8 and 18 months 
would be an important next step to consider.  Newborn state screening data, which 
includes 17-OHP values, as well as data from early intervention programs and NICU 
follow-up clinics, are promising sources of information for such studies.  
Reducing future health risks for premature infants is important.  Early work seems to 
indicate that understanding the factors that can lead to altered adrenocortical resting and 
responsivity patterns in premature infants may be important for understanding their future 
problems in learning and development.  Beyond the demonstration that one of the two 
major and prevalent types of stressors in premature infants is related to 17-OHP values at 
37 postmenstrual weeks of age, future research is needed to explore the relationship 
between 17-OHP values and cumulative stressor exposure at 37 postmenstrual weeks of 




enduring implications of early 17-OHP values and exposure to recurrent pain-associated 
procedures in the population of infants who are born prematurely remain to be elucidated.   
Conclusions 
This research extends what is known about factors influencing the adrenocorticoid 
phenotype of premature infants at 37 postmenstrual weeks of age.  Few studies have 
examined cortisol values in the general population of premature infants in relation to 
pain-associated procedural exposure and none have looked at these values at 37 
postmenstrual weeks of age in relation to procedural exposure.  Furthermore, no studies 
could be identified that have examined 17-OHP values in relation to pain-associated 
procedural exposure.  This study succeeded in showing that there was a relationship 
between recurrent pain-associated procedural exposure and 17-OHP values in premature 
infants, although multicollinearity limited analysis and exposure measurements may have 
been underestimated.  The information gained by this research can nevertheless be used 
to inform future work on pain-associated stress and HPA axis adaptations in premature 
infants.   
Recurrent exposure to pain-associated procedures may diminish the production of 17-
OHP in premature infants, and has previously been shown to be negatively correlated 
with early developmental milestones.  Even though recurrent stressful exposures in NICU 
reflect efforts to bring premature infants to health, these stressful procedures may 
contribute to some of the developmental difficulties observed in later childhood. While 
more research is needed to clarify these early findings, it is important to consider that 




may cause lasting changes in the endocrinologic function of some of the patients in 
whom we are aiming to restore health.   
Until further evidence emerges, the impact of recurrent skin breaking procedures should 
not be presumed as transient by caretakers in the NICU.  In order to do more for our 
smallest and youngest patients, we are beginning to find ourselves examining how we can 
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